GLP-1 Market
LLY $1136.11 ▼ -0.2% NVO $42.53 ▼ -2.1% PFE $27.55 ▼ -0.6% VKTX $29.95 ▼ -5.0% KLRA $13.45 ▼ -2.2% GPCR $38.95 ▲ +1.3% RHHBY $54.90 ▲ +0.2%
Market data delayed up to 20 min · Source: Twelve Data

Empowering you to have better conversations with your doctor.

Subscribe
About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

Tacrolimus

Company
University of Alberta
Mechanism
Mechanism not yet reported
Route
Route not yet reported
Recruiting trials
47 recruiting

Efficacy results: Not yet reported

Find a Clinical Trial Near Me

47 recruiting studies currently listed on ClinicalTrials.gov.

Data source: ClinicalTrials.gov · trial data as of Sep 16, 2026

Find a Clinical Trial Near Me

See recruiting studies for Tacrolimus and check eligibility with the study team.

Select conditions
Match
Treatment type

"Added to GLP-1" means the investigational treatment is being studied on top of an existing GLP-1-based therapy.

Your ZIP code is only used to calculate distance to trial sites — it isn't stored.

Trial details
  • Recruiting NCT NCT01241864

    Islet Transplantation in Type 1 Diabetic Kidney Allograft

    Not yet reported University of Chicago 10 participants Est. completion 2026-12 1 site Stand-alone
    Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Recruiting NCT NCT01804634

    Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

    Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 60 participants Est. completion 2030-01 3 sites Stand-alone
    Other conditions: Refractory and/or Relapsed Metastatic Solid Tumors
    View official trial listing →
  • Recruiting NCT NCT03314974

    Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders

    Not yet reported Masonic Cancer Center, University of Minnesota 300 participants Est. completion 2028-06-10 1 site Stand-alone
    Other conditions: Acute Leukemia, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Lymphoma, Chronic Myelogenous Leukemia, Plasma Cell Leukemia, Myeloproliferative Neoplasms, Myelofibrosis, Myelodysplasia, Refractory Anemia, High Risk Anemia, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Marginal Zone B-Cell Lymphoma, Follicular Lymphoma, Lymphoplasmacytic Lymphoma, Mantle-Cell Lymphoma, Prolymphocytic Leukemia, Diffuse Large Cell Non Hodgkins Lymphoma, Lymphoblastic Lymphoma, Burkitt Lymphoma, High Grade Non-Hodgkin's Lymphoma, Adult, Multiple Myeloma, Juvenile Myelomonocytic Leukemia, Biphenotypic/Undifferentiated/Prolymphocytic Leukemias, MRD Positive Leukemia, Natural Killer Cell Malignancies, Acquired Bone Marrow Failure Syndromes
    View official trial listing →
  • Recruiting NCT NCT04022239

    Bendamustine With or Without Cyclophosphamide in Preventing GVHD in Patients Undergoing Stem Cell Transplant

    Not yet reported, Not yet reported M.D. Anderson Cancer Center 25 participants Est. completion 2027-07-31 1 site Stand-alone
    Other conditions: Hematopoietic and Lymphoid System Neoplasm
    View official trial listing →
  • Recruiting NCT NCT04182984

    TheRapeutic Effect of Different immunosuppressAnts on Non-Thymoma Ocular Myasthenia Gravis: a Real-world Study

    Tang-Du Hospital 200 participants Est. completion 2026-06-30 1 site
    Other conditions: Ocular Myasthenia Gravis
    View official trial listing →
  • Recruiting NCT NCT04187105

    BMT-06: Study of Intensity Modulated Total Marrow Irradiation (IM-TMI)

    Not yet reported University of Illinois at Chicago 27 participants Est. completion 2026-12 1 site
    Other conditions: Acute Leukemia, MDS
    View official trial listing →
  • Recruiting NCT NCT04370301

    Reduced Intensity Haploidentical Transplantation for the Treatment of Primary or Secondary Myelofibrosis

    Not yet reported Fred Hutchinson Cancer Center 20 participants Est. completion 2029-08-31 1 site Stand-alone
    Other conditions: Primary Myelofibrosis, Secondary Myelofibrosis
    View official trial listing →
  • Recruiting NCT NCT04380740

    Extended vs Short-term Abatacept Dosing for Graft Versus Host Disease Prophylaxis

    Not yet reported Boston Children's Hospital 160 participants Est. completion 2028-06 15 sites Stand-alone
    Other conditions: Graft Vs Host Disease
    View official trial listing →
  • Recruiting NCT NCT04477629

    Belatacept in De Novo Heart Transplantation

    Not yet reported NYU Langone Health 12 participants Est. completion 2026-09 2 sites Stand-alone
    Other conditions: Heart Transplantation
    View official trial listing →
  • Recruiting NCT NCT04877288

    A Study to Evaluate the Benefits and Risks of Conversion of Existing Adolescent Kidney Transplant Recipients Aged 12 to <18 Years to a Belatacept-based Immunosuppressive Regimen as Compared to Continuation of a Calcineurin Inhibitor-based Regimen, and Their Adherence to Immunosuppressive Medications

    Not yet reported Bristol-Myers Squibb 102 participants Est. completion 2034-06-30 38 sites Stand-alone
    Other conditions: Renal Allograft Recipients
    View official trial listing →
  • Recruiting NCT NCT05027945

    A Phase II Study of Allogeneic Hematopoietic Stem Cell Transplant for Subjects With VEXAS (Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic) Syndrome

    Not yet reported National Cancer Institute (NCI) 54 participants Est. completion 2031-07-01 1 site Stand-alone
    Other conditions: Immunodeficiency, Hematopoietic Stem Cell Transplantation
    View official trial listing →
  • Recruiting NCT NCT05031897

    Two Step Haplo With Radiation Conditioning

    Not yet reported Thomas Jefferson University 63 participants Est. completion 2032-04 1 site Stand-alone
    Other conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Adult T-Cell Leukemia/Lymphoma, Aplastic Anemia, Chronic Lymphocytic Leukemia, Chronic Myeloid Leukemia, BCR-ABL1 Positive, Chronic Myelomonocytic Leukemia, Essential Thrombocythemia, Hematopoietic and Lymphatic System Neoplasm, Hodgkin Lymphoma, Multiple Myeloma, Myelodysplastic Syndrome, Myelofibrosis, Myeloid Neoplasm, Non-Hodgkin Lymphoma, Polycythemia Vera, Small Lymphocytic Lymphoma
    View official trial listing →
  • Recruiting NCT NCT05242315

    Extended-Release Tacrolimus Following Liver Transplantation

    Not yet reported University of Alberta 94 participants Est. completion 2034-02-15 1 site
    Metabolic syndromeCardiovascular disease Other conditions: Liver Transplant; Complications, Renal Insufficiency, Immunosuppressant Adverse Reaction
    View official trial listing →
  • Recruiting NCT NCT05726305

    Transplantation of Uterus for Uterine infertiLIty From Living Donor or Deceased Donor

    Not yet reported Rennes University Hospital 16 participants Est. completion 2037-12 1 site Stand-alone
    Other conditions: Uterine Factor Infertility
    View official trial listing →
  • Recruiting NCT NCT06033196

    Tocilizumab in Lung Transplantation

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 350 participants Est. completion 2029-01-08 21 sites Stand-alone
    Other conditions: Lung Transplant
    View official trial listing →
  • Recruiting NCT NCT06055608

    Advancing Transplantation Outcomes in Children

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 200 participants Est. completion 2028-06-30 20 sites Stand-alone
    Other conditions: Kidney Transplant
    View official trial listing →
  • Recruiting NCT NCT06235892

    Tacrolimus Minimization in Kidney Transplant Recipients Selected According to the AGORA Algorithm for Their Low Immunological Risk and Medium-term Graft Failure

    Not yet reported Nantes University Hospital 300 participants Est. completion 2028-12-10 3 sites Stand-alone
    Other conditions: Organ Grafts
    View official trial listing →
  • Recruiting NCT NCT06265584

    Trial of 2 Step ATG for Prevention of Acute GVHD Post Allogeneic Stem Cell Transplant

    Not yet reported University of Alabama at Birmingham 56 participants Est. completion 2028-11 1 site Stand-alone
    Other conditions: Acute Leukemia, Myelodysplastic Syndrome, Myeloproliferative Disorders
    View official trial listing →
  • Recruiting NCT NCT06268769

    Tacrolimus C:D Ratio Measured in Renal Transplant Recipients Treated With Once-daily Prolonged-release Drugs

    Not yet reported Edward Geissler 300 participants Est. completion 2029-09 9 sites Stand-alone
    Other conditions: Immunosuppression
    View official trial listing →
  • Recruiting NCT NCT06287944

    225Ac-DOTA-Anti-CD38 Daratumumab Monoclonal Antibody With Fludarabine, Melphalan and Total Marrow and Lymphoid Irradiation as Conditioning Treatment for Donor Stem Cell Transplant in Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Myelodysplastic Syndrome

    Not yet reported City of Hope Medical Center 15 participants Est. completion 2028-05-19 1 site Stand-alone
    Other conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Myelodysplastic Syndrome
    View official trial listing →
  • Recruiting NCT NCT06315309

    Trial of 2 Step ATG for Acute GVHD Prevention Post Myeloablative Allogeneic Stem Cell Transplant

    Not yet reported University of Alabama at Birmingham 29 participants Est. completion 2027-05 1 site Stand-alone
    Other conditions: GVHD,Acute, Acute Leukemia, Myelodysplastic Syndromes, Myeloproliferative Disorders
    View official trial listing →
  • Recruiting NCT NCT06394232

    Safety & Efficacy of Eyecyte-RPE™ in Patients With Geographic Atrophy Secondary to Dry Age-related Macular Degeneration.

    Not yet reported, Not yet reported Eyestem Research Pvt. Ltd. 54 participants Est. completion 2030-12 3 sites
    Other conditions: Retinal Disease, Macular Degeneration, Age-Related Macular Degeneration, Geographic Atrophy, Eye Diseases
    View official trial listing →
  • Recruiting NCT NCT06412497

    MT2023-20: Hematopoietic Cell Transplant With Reduced Intensity Conditioning and Post-transplant Cyclophosphamide for Severe Aplastic Anemia and Other Forms of Acquired Bone Marrow Failure.

    Not yet reported Masonic Cancer Center, University of Minnesota 60 participants Est. completion 2036-05-01 1 site Stand-alone
    Other conditions: Severe Aplastic Anemia, Acquired Amegakaryocytic Thrombocytopenia, Acquired Pure Red Cell Aplasia, Paroxysmal Nocturnal Hemoglobinuria
    View official trial listing →
  • Recruiting NCT NCT06478017

    Belatacept in Heart Transplantation

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 66 participants Est. completion 2028-01-31 6 sites Stand-alone
    Other conditions: Heart Transplant
    View official trial listing →
  • Recruiting NCT NCT06529536

    Utilising Genotype Informed Bayesian Dosing of Tacrolimus in Children Post Solid Organ Transplantation.

    Not yet reported Murdoch Childrens Research Institute 45 participants Est. completion 2027-08-02 1 site Stand-alone
    Other conditions: Solid Organ Transplant
    View official trial listing →
  • Recruiting NCT NCT06701825

    Effectiveness and Cost-effectiveness of a Pre-emptive Genotyping Strategy in Patients Receiving Tacrolimus

    Not yet reported Instituto de Investigación Hospital Universitario La Paz 114 participants Est. completion 2026-12-31 1 site Stand-alone
    Other conditions: Kidney Disease, Chronic, Transplant Recipient (Kidney), Immunosuppression
    View official trial listing →
  • Recruiting NCT NCT06777719

    Eight-Treg Study:Trial of Adoptive Immunotherapy With Autologous ex Vivo Expanded Regulatory CD8+ T Cells in Living Donor Kidney Transplant Recipients

    Not yet reported Nantes University Hospital 9 participants Est. completion 2027-05-18 1 site Stand-alone
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Recruiting NCT NCT06802315

    Intensity Modulated Total Marrow Irradiation in Fully Human Leukocyte Antigen (HLA)-Matched and Partially-HLA Mismatched Allogeneic Transplantation Patients With High-Risk Acute Myeloid Leukemia (AML), Chronic Myeloid Leukemia (CML), and Myelodysplastic Syndrome (MDS)

    Not yet reported University of Illinois at Chicago 38 participants Est. completion 2032-03 1 site Stand-alone
    Other conditions: Acute Myeloid Leukemia, Relapsed, Adult, Acute Myeloid Leukemia Refractory, Chronic Myeloid Leukemia - Accelerated Phase, Myelodysplastic Syndromes
    View official trial listing →
  • Recruiting NCT NCT06829719

    TTV-based mAnagement Of Long-term ImmunosuppreSsion in Kidney Transplantation

    Not yet reported Hospices Civils de Lyon 600 participants Est. completion 2031-02-02 4 sites Stand-alone
    Other conditions: Infection, Cancer, Rejection, Kidney Transplantation
    View official trial listing →
  • Recruiting NCT NCT06833463

    Tacrolimus and Risk Factors for Glucose Metabolism Disorders in Kidney Transplant Patients

    Chiesi Poland Sp. z o.o. 120 participants Est. completion 2028-01-30 6 sites
    Other conditions: Kidney Transplant
    View official trial listing →
  • Recruiting NCT NCT06918990

    Treatment of Antibody-Mediated Rejection (ABMR) With CarBel

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 25 participants Est. completion 2027-06-30 11 sites Stand-alone
    Other conditions: Kidney Transplant Rejection
    View official trial listing →
  • Recruiting NCT NCT06962800

    A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Primary Membranous Nephropathy (PMN)

    Not yet reported Biogen 180 participants Est. completion 2031-01-17 112 sites Stand-alone
    Other conditions: Primary Membranous Nephropathy
    View official trial listing →
  • Recruiting NCT NCT07042035

    Study of Tacrolimus Melt-Dose® for Lung Transplant Patients

    Chiesi España, S.A.U. 240 participants Est. completion 2026-12-31 2 sites
    Other conditions: Lung Trasplant, Lung Transplantation
    View official trial listing →
  • Recruiting NCT NCT07104799

    Momelotinib During and After HCT in Myelofibrosis

    Not yet reported Massachusetts General Hospital 28 participants Est. completion 2030-01 1 site Stand-alone
    Other conditions: Myelofibrosis, Hematopoietic Cell Transplantation (HCT)
    View official trial listing →
  • Recruiting NCT NCT07204275

    Evaluation of Efficacy, Safety, and Tolerability of Povetacicept in Participants With Primary Membranous Nephropathy (pMN)

    Not yet reported, Not yet reported Vertex Pharmaceuticals Incorporated 176 participants Est. completion 2028-12-29 114 sites
    Other conditions: Primary Membranous Nephropathy
    View official trial listing →
  • Recruiting NCT NCT07206277

    Fibroscan to Guide Post Transplant Immunosuppression Minimization

    Not yet reported University of Alberta 50 participants Est. completion 2028-12-31 1 site Stand-alone
    Other conditions: Immunosuppression
    View official trial listing →
  • Recruiting NCT NCT07216443

    Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome

    Not yet reported Orca Biosystems, Inc. 80 participants Est. completion 2028-12 6 sites Stand-alone
    Other conditions: Leukemia, Myeloid, Acute, Myelodysplastic Syndromes, Mixed Phenotype Acute Leukemia
    View official trial listing →
  • Recruiting NCT NCT07238712

    Optimization of Post-transplantation Benadamustine and Cyclophosphamide in Patients With High-risk Myeloid Malignancies and a Partially Mismatched Donor

    Not yet reported St. Petersburg State Pavlov Medical University 60 participants Est. completion 2026-12-10 1 site Stand-alone
    Other conditions: Acute Myeloid Leukemia (AML), Chronic Myeloid Leukemia, Myelodysplastic Syndromes (MDS), Myeloprolipherative Neoplsm, Atypical Chronic Myeloid Leukemia
    View official trial listing →
  • Recruiting NCT NCT07249346

    Dose-Expansion Study of Low Dose Post-Transplant Cyclophosphamide/Tacrolimus/Ruxolitinib for Graft-versus-Host Disease (GVHD) Prophylaxis in Myeloablative Allogeneic Peripheral Blood Stem Cell Transplantation

    Not yet reported Hannah Choe, MD 124 participants Est. completion 2027-06-01 3 sites Stand-alone
    Other conditions: Leukemia, Myelodysplasia, Chronic Myelomonocytic Leukemia
    View official trial listing →
  • Recruiting NCT NCT07297173

    Phase 1 Study of Chemotherapy Plus HLA-mismatched GPBMC Infusion Bridging to Allo-HSCT for R/R Leukemia

    Not yet reported Beijing 302 Hospital 5 participants Est. completion 2030-12-01 1 site Stand-alone
    Other conditions: Relapsed Leukemia, Refractory Leukemia
    View official trial listing →
  • Recruiting NCT NCT07302776

    TACrolimus Targeted Immunosuppression Cessation in ALlogeneic HCT

    Not yet reported Stanford University 50 participants Est. completion 2028-02 1 site Stand-alone
    Other conditions: GVHD, Hematopoietic Cell Transplantation (HCT), Acute Myeloid Leukemia (AML), Myelodysplastic Syndromes, Myelofibrosis (MF), Chronic Myeloid Leukemia (CML), Chronic Myelomonocytic Leukemia (CMML)
    View official trial listing →
  • Recruiting NCT NCT07493538

    MT2025-35 Allogeneic Hematopoietic Stem Cell Transplantation Using Reduced Intensity Conditioning Treosulfan and Fludarabine, With Post-Transplant Cytoxan (PTCy) for the Treatment of Hematological Diseases

    Not yet reported Masonic Cancer Center, University of Minnesota 132 participants Est. completion 2035-03 1 site Stand-alone
    Other conditions: AML, MDS, Acute Leukemia, Acute Myeloid Leukemia, Myelodysplastic Syndromes
    View official trial listing →
  • Recruiting NCT NCT07508787

    A Study Comparing Siplizumab With Rabbit Anti-Thymocyte Globulin to Help the Body Accept a Kidney Transplant

    Not yet reported Nefro Avillion Clinical Development, LLC 120 participants Est. completion 2028-03-28 7 sites
    Other conditions: Renal Transplant Failure and Rejection
    View official trial listing →
  • Recruiting NCT NCT07566377

    Cord Blood Transplantation in Children and Young Adults With Blood Cancer

    Not yet reported Memorial Sloan Kettering Cancer Center 71 participants Est. completion 2030-04-28 1 site Stand-alone
    Other conditions: Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndromes, Non-hodgkin Lymphoma, Hodgkin Lymphoma, Leukemia, Lymphoma, Graft-versus-host Disease
    View official trial listing →
  • Recruiting NCT NCT07572071

    Safety and Feasibility of Bilateral Striatal Transplantation of DopaCell in Parkinson's Disease

    Not yet reported Royan Institute 6 participants Est. completion 2030-08-01 3 sites Stand-alone
    Other conditions: Parkinson Disease (PD)
    View official trial listing →
  • Recruiting NCT NCT07582172

    Total Marrow and Lymphoid Irradiation in Combination With Fludarabine and Melphalan as Conditioning for Allogeneic Peripheral Blood Stem Cell Hematopoietic Cell Transplant in Older Patients With Refractory and Relapsed Acute Myeloid Leukemia and High-risk Myelodysplastic Syndrome

    Not yet reported City of Hope Medical Center 35 participants Est. completion 2029-04-05 1 site Stand-alone
    Other conditions: Acute Myeloid Leukemia With Complex Karyotype, Myelodysplastic Chronic Myelomonocytic Leukemia, Myelodysplastic Syndrome, Recurrent Acute Myeloid Leukemia, Recurrent Myelodysplastic Chronic Myelomonocytic Leukemia, Recurrent Myelodysplastic Syndrome, Recurrent Secondary Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia, Refractory Myelodysplastic Chronic Myelomonocytic Leukemia, Refractory Myelodysplastic Syndrome, Refractory Secondary Acute Myeloid Leukemia
    View official trial listing →
  • Recruiting NCT NCT07775235

    Treatment Response in Immune-mediated Myositis Associated Rapidly-progressing Interstitial Lung Disease

    Singapore General Hospital 80 participants Est. completion 2029-07-01 1 site
    Other conditions: Interstitial Lung Disease, Myositis
    View official trial listing →
  • Completed NCT NCT00002657

    SWOG-9239 Reduction of Immunosuppression Plus Interferon Alfa and Combination Chemotherapy in Treating Patients With Malignant Tumors That Develop After Organ Transplant

    Not yet reported SWOG Cancer Research Network 20 participants Est. completion 2011-07 86 sites
    Other conditions: Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm
    View official trial listing →
  • Completed NCT NCT00002809

    Bone Marrow Transplant Plus Cyclophosphamide and Total-Body Irradiation in Treating Patients With Hematologic Cancer

    Not yet reported Temple University 10 participants Est. completion 2003-12 1 site
    Other conditions: Leukemia, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Diseases
    View official trial listing →
  • Completed NCT NCT00002831

    Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous or Acute Leukemia

    Not yet reported, Not yet reported M.D. Anderson Cancer Center 24 participants Est. completion 2002-12-31 1 site Stand-alone
    Other conditions: Leukemia
    View official trial listing →
  • Completed NCT NCT00003572

    Total-Body Irradiation, Tacrolimus, and Mycophenolate Mofetil Plus Bone Marrow Transplantation in Treating Patients With Hematologic Cancers

    Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 20 participants Est. completion 2002-04 1 site
    Other conditions: Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes
    View official trial listing →
  • Completed NCT NCT00004145

    Chemotherapy Plus Biological Therapy Followed By Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer

    Not yet reported University of Chicago 16 participants Est. completion 2011-08 1 site Stand-alone
    Other conditions: Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes
    View official trial listing →
  • Withdrawn NCT NCT00004878

    Donor Lymphocytes to Prevent Graft-Versus-Host Disease in Patients With Chronic Myeloid Leukemia

    Not yet reported Jonsson Comprehensive Cancer Center
    Other conditions: Graft Versus Host Disease, Leukemia
    View official trial listing →
  • Completed NCT NCT00006042

    Cyclophosphamide Plus Bone Marrow Transplantation in Treating Patients With Hematologic Cancer

    Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 1 site
    Other conditions: Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Diseases
    View official trial listing →
  • Completed NCT NCT00007787

    Antibody and Delayed Cyclosporine Versus Initial Cyclosporine Alone in Patients Receiving Kidney Transplants

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 350 participants Est. completion 2004-03 1 site Stand-alone
    Other conditions: Kidney Transplantation, Chronic Allograft Nephropathy
    View official trial listing →
  • Completed NCT NCT00027573

    Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic or Unresectable Kidney Cancer

    Not yet reported Alliance for Clinical Trials in Oncology 36 participants Est. completion 2006-06 6 sites Stand-alone
    Other conditions: Kidney Cancer
    View official trial listing →
  • Completed NCT NCT00028171

    Pharmacokinetics of Tacrolimus in Kidney Transplant Recipients: Once Daily Versus Twice Daily Dosing

    Not yet reported National Center for Research Resources (NCRR) 1 site
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT00039377

    Chemotherapy, Imatinib Mesylate, and Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia

    Not yet reported National Cancer Institute (NCI) 58 participants Est. completion 2014-02 97 sites Stand-alone
    Other conditions: Adult Acute Lymphoblastic Leukemia in Remission
    View official trial listing →
  • Terminated NCT NCT00041288

    Study Of Two Non-Myeloablative Stem Cell Transplant Strategies For Low-Grade Lymphoma And CLL

    Not yet reported University of Texas Southwestern Medical Center 10 participants Est. completion 2003-01 23 sites
    Other conditions: Leukemia, Lymphoma
    View official trial listing →
  • Terminated NCT NCT00048399

    Stem Cell Transplantation for Patients With Graft Failure Following an Allogeneic Transplant, Using Identical or Near Identical Donors and Less Toxic Conditioning With CAMPATH 1H

    Not yet reported, Not yet reported Baylor College of Medicine 40 participants Est. completion 2003-10-31 2 sites
    Other conditions: Graft Failure
    View official trial listing →
  • Completed NCT NCT00078559

    Combination Immunosuppressive Therapy to Prevent Kidney Transplant Rejection in Adults

    Not yet reported, Not yet reported University of Wisconsin, Madison 10 participants Est. completion 2010-02 1 site Stand-alone
    Other conditions: Kidney Transplantation, Kidney Disease
    View official trial listing →
  • Terminated NCT NCT00086346

    Study Evaluating of Calcineurin Inhibitor and Sirolimus (Rapamune) Treatment in Liver Transplant Recipients

    Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 607 participants Est. completion 2008-07 42 sites
    Other conditions: Liver Transplantation
    View official trial listing →
  • Completed NCT NCT00087581

    Study of Therapeutic Monitoring of Mycophenolate Mofetil (MMF/CellCept) After Kidney Transplantation

    Not yet reported Hoffmann-La Roche 720 participants Est. completion 2007-09 57 sites Stand-alone
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT00089011

    Tacrolimus and Mycophenolate Mofetil in Preventing Graft-Versus-Host Disease in Patients Who Have Undergone Total-Body Irradiation With or Without Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant for Hematologic Cancer

    Not yet reported Fred Hutchinson Cancer Center 150 participants Est. completion 2018-07 5 sites Stand-alone
    Obstructive sleep apnea Other conditions: Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, Blastic Phase Chronic Myelogenous Leukemia, Childhood Acute Lymphoblastic Leukemia in Remission, Childhood Acute Myeloid Leukemia in Remission, Childhood Burkitt Lymphoma, Childhood Chronic Myelogenous Leukemia, Childhood Diffuse Large Cell Lymphoma, Childhood Immunoblastic Large Cell Lymphoma, Childhood Myelodysplastic Syndromes, Childhood Nasal Type Extranodal NK/T-cell Lymphoma, Chronic Phase Chronic Myelogenous Leukemia, Contiguous Stage II Adult Burkitt Lymphoma, Contiguous Stage II Adult Diffuse Large Cell Lymphoma, Contiguous Stage II Adult Diffuse Mixed Cell Lymphoma, Contiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma, Contiguous Stage II Adult Immunoblastic Large Cell Lymphoma, Contiguous Stage II Adult Lymphoblastic Lymphoma, Contiguous Stage II Grade 1 Follicular Lymphoma, Contiguous Stage II Grade 2 Follicular Lymphoma, Contiguous Stage II Grade 3 Follicular Lymphoma, Contiguous Stage II Mantle Cell Lymphoma, Contiguous Stage II Marginal Zone Lymphoma, Contiguous Stage II Small Lymphocytic Lymphoma, Cutaneous B-cell Non-Hodgkin Lymphoma, de Novo Myelodysplastic Syndromes, Essential Thrombocythemia, Hepatosplenic T-cell Lymphoma, Intraocular Lymphoma, Nodal Marginal Zone B-cell Lymphoma, Noncontiguous Stage II Adult Burkitt Lymphoma, Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma, Noncontiguous Stage II Adult Diffuse Mixed Cell Lymphoma, Noncontiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma, Noncontiguous Stage II Adult Immunoblastic Large Cell Lymphoma, Noncontiguous Stage II Adult Lymphoblastic Lymphoma, Noncontiguous Stage II Grade 1 Follicular Lymphoma, Noncontiguous Stage II Grade 2 Follicular Lymphoma, Noncontiguous Stage II Grade 3 Follicular Lymphoma, Noncontiguous Stage II Mantle Cell Lymphoma, Noncontiguous Stage II Marginal Zone Lymphoma, Noncontiguous Stage II Small Lymphocytic Lymphoma, Noncutaneous Extranodal Lymphoma, Peripheral T-cell Lymphoma, Polycythemia Vera, Post-transplant Lymphoproliferative Disorder, Previously Treated Myelodysplastic Syndromes, Primary Myelofibrosis, Prolymphocytic Leukemia, Recurrent Adult Acute Lymphoblastic Leukemia, Recurrent Adult Acute Myeloid Leukemia, Recurrent Adult Burkitt Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma, Recurrent Adult Diffuse Mixed Cell Lymphoma, Recurrent Adult Diffuse Small Cleaved Cell Lymphoma, Recurrent Adult Grade III Lymphomatoid Granulomatosis, Recurrent Adult Hodgkin Lymphoma, Recurrent Adult Immunoblastic Large Cell Lymphoma, Recurrent Adult Lymphoblastic Lymphoma, Recurrent Adult T-cell Leukemia/Lymphoma, Recurrent Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood Acute Myeloid Leukemia, Recurrent Childhood Anaplastic Large Cell Lymphoma, Recurrent Childhood Grade III Lymphomatoid Granulomatosis, Recurrent Childhood Large Cell Lymphoma, Recurrent Childhood Lymphoblastic Lymphoma, Recurrent Childhood Small Noncleaved Cell Lymphoma, Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Grade 3 Follicular Lymphoma, Recurrent Mantle Cell Lymphoma, Recurrent Marginal Zone Lymphoma, Recurrent Mycosis Fungoides/Sezary Syndrome, Recurrent Small Lymphocytic Lymphoma, Recurrent/Refractory Childhood Hodgkin Lymphoma, Refractory Chronic Lymphocytic Leukemia, Refractory Hairy Cell Leukemia, Refractory Multiple Myeloma, Relapsing Chronic Myelogenous Leukemia, Small Intestine Lymphoma, Splenic Marginal Zone Lymphoma, Stage I Adult Burkitt Lymphoma, Stage I Adult Diffuse Large Cell Lymphoma, Stage I Adult Diffuse Mixed Cell Lymphoma, Stage I Adult Diffuse Small Cleaved Cell Lymphoma, Stage I Adult Immunoblastic Large Cell Lymphoma, Stage I Adult Lymphoblastic Lymphoma, Stage I Adult T-cell Leukemia/Lymphoma, Stage I Childhood Anaplastic Large Cell Lymphoma, Stage I Childhood Large Cell Lymphoma, Stage I Childhood Lymphoblastic Lymphoma, Stage I Childhood Small Noncleaved Cell Lymphoma, Stage I Chronic Lymphocytic Leukemia, Stage I Cutaneous T-cell Non-Hodgkin Lymphoma, Stage I Grade 1 Follicular Lymphoma, Stage I Grade 2 Follicular Lymphoma, Stage I Grade 3 Follicular Lymphoma, Stage I Mantle Cell Lymphoma, Stage I Marginal Zone Lymphoma, Stage I Multiple Myeloma, Stage I Small Lymphocytic Lymphoma, Stage IA Mycosis Fungoides/Sezary Syndrome, Stage IB Mycosis Fungoides/Sezary Syndrome, Stage II Adult T-cell Leukemia/Lymphoma, Stage II Childhood Anaplastic Large Cell Lymphoma, Stage II Childhood Large Cell Lymphoma, Stage II Childhood Lymphoblastic Lymphoma, Stage II Childhood Small Noncleaved Cell Lymphoma, Stage II Chronic Lymphocytic Leukemia, Stage II Cutaneous T-cell Non-Hodgkin Lymphoma, Stage II Multiple Myeloma, Stage IIA Mycosis Fungoides/Sezary Syndrome, Stage IIB Mycosis Fungoides/Sezary Syndrome, Stage III Adult Burkitt Lymphoma, Stage III Adult Diffuse Large Cell Lymphoma, Stage III Adult Diffuse Mixed Cell Lymphoma, Stage III Adult Diffuse Small Cleaved Cell Lymphoma, Stage III Adult Immunoblastic Large Cell Lymphoma, Stage III Adult Lymphoblastic Lymphoma, Stage III Adult T-cell Leukemia/Lymphoma, Stage III Childhood Anaplastic Large Cell Lymphoma, Stage III Childhood Large Cell Lymphoma, Stage III Childhood Lymphoblastic Lymphoma, Stage III Childhood Small Noncleaved Cell Lymphoma, Stage III Chronic Lymphocytic Leukemia, Stage III Cutaneous T-cell Non-Hodgkin Lymphoma, Stage III Grade 1 Follicular Lymphoma, Stage III Grade 2 Follicular Lymphoma, Stage III Grade 3 Follicular Lymphoma, Stage III Mantle Cell Lymphoma, Stage III Marginal Zone Lymphoma, Stage III Multiple Myeloma, Stage III Small Lymphocytic Lymphoma, Stage IIIA Mycosis Fungoides/Sezary Syndrome, Stage IIIB Mycosis Fungoides/Sezary Syndrome, Stage IV Adult Burkitt Lymphoma, Stage IV Adult Diffuse Large Cell Lymphoma, Stage IV Adult Diffuse Mixed Cell Lymphoma, Stage IV Adult Diffuse Small Cleaved Cell Lymphoma, Stage IV Adult Immunoblastic Large Cell Lymphoma, Stage IV Adult Lymphoblastic Lymphoma, Stage IV Adult T-cell Leukemia/Lymphoma, Stage IV Childhood Anaplastic Large Cell Lymphoma, Stage IV Childhood Large Cell Lymphoma, Stage IV Childhood Lymphoblastic Lymphoma, Stage IV Childhood Small Noncleaved Cell Lymphoma, Stage IV Chronic Lymphocytic Leukemia, Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma, Stage IV Grade 1 Follicular Lymphoma, Stage IV Grade 2 Follicular Lymphoma, Stage IV Grade 3 Follicular Lymphoma, Stage IV Mantle Cell Lymphoma, Stage IV Marginal Zone Lymphoma, Stage IV Small Lymphocytic Lymphoma, Stage IVA Mycosis Fungoides/Sezary Syndrome, Stage IVB Mycosis Fungoides/Sezary Syndrome, Testicular Lymphoma, Untreated Adult Acute Lymphoblastic Leukemia, Untreated Adult Acute Myeloid Leukemia, Untreated Childhood Acute Lymphoblastic Leukemia, Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies, Waldenström Macroglobulinemia
    View official trial listing →
  • Completed NCT NCT00096096

    Tacrolimus and Mycophenolate Mofetil in Preventing Acute Graft-Versus-Host Disease in Patients With Advanced Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplantation

    Not yet reported Fred Hutchinson Cancer Center 1 site
    Other conditions: Chronic Myeloproliferative Disorders, Graft Versus Host Disease, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Diseases
    View official trial listing →
  • Terminated NCT NCT00096460

    Autologous or Donor Stem Cell Transplantation in Treating Patients With Recurrent Non-Hodgkin's Lymphoma (BMT CTN 0202)

    Not yet reported, Not yet reported Medical College of Wisconsin 30 participants Est. completion 2009-03 30 sites
    Other conditions: Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Grade 3 Follicular Lymphoma, Follicular Lymphoma
    View official trial listing →
  • Completed NCT NCT00104975

    Alemtuzumab and Combination Chemotherapy Followed By Donor Lymphocytes in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer

    Not yet reported Yale University 20 participants Est. completion 2008-05 1 site
    Other conditions: Chronic Myeloproliferative Disorders, Leukemia, Lymphoma, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
    View official trial listing →
  • Completed NCT NCT00109993

    Campath-1H + FK506 and Methylprednisolone for GVHD

    Not yet reported Case Comprehensive Cancer Center 34 participants Est. completion 2007-05 6 sites
    Other conditions: Breast Cancer, Chronic Myeloproliferative Disorders, Gestational Trophoblastic Tumor, Graft Versus Host Disease, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Diseases, Neuroblastoma, Ovarian Cancer, Testicular Germ Cell Tumor
    View official trial listing →
  • Completed NCT NCT00113269

    Safety/Efficacy of Induction Agents With Tacrolimus, MMF, and Rapid Steroid Withdrawal in Renal Transplant Recipients

    Not yet reported Astellas Pharma Inc 501 participants Est. completion 2009-03 29 sites Stand-alone
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT00116103

    A Study of the Safety and Efficacy of Tacrolimus Inhalation Aerosol in Subjects With Persistent Asthma

    Not yet reported Astellas Pharma Inc Est. completion 2006-04 21 sites
    Other conditions: Asthma
    View official trial listing →
  • Terminated NCT NCT00121186

    S0501 Fludarabine, Melphalan, and Donor Stem Cell Transplant Followed By Tacrolimus and Methotrexate in Treating Patients for Relapsed Lymphoma

    Not yet reported SWOG Cancer Research Network 1 participants Est. completion 2011-12 33 sites Stand-alone
    Other conditions: Lymphoma
    View official trial listing →
  • Completed NCT NCT00125307

    Tacrolimus for the Treatment of Systemic Lupus Erythematosus With Membranous Nephritis

    Not yet reported Chinese University of Hong Kong 20 participants Est. completion 2008-02 1 site
    Other conditions: Lupus Nephritis, Lupus Erythematosus, Systemic
    View official trial listing →
  • Completed NCT NCT00132691

    Multicenter Uveitis Steroid Treatment (MUST) Trial

    Not yet reported JHSPH Center for Clinical Trials 255 participants Est. completion 2010-12 23 sites
    Other conditions: Uveitis
    View official trial listing →
  • Terminated NCT NCT00133172

    Effect of Rapid Steroid Withdrawal on Subclinical Markers of Rejection

    Not yet reported Astellas Pharma Inc 85 participants Est. completion 2007-03 14 sites Stand-alone
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT00134394

    Etanercept With Tacrolimus for Psoriasis

    Not yet reported University of Medicine and Dentistry of New Jersey 20 participants Est. completion 2007-12 1 site
    Other conditions: Psoriasis
    View official trial listing →
  • Completed NCT NCT00135694

    Gradual Withdrawal of Immune System Suppressing Drugs in Patients Receiving a Liver Transplant

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 275 participants Est. completion 2015-09 8 sites Stand-alone
    Other conditions: Hepatitis C, Hepatitis C, Chronic, Nonimmune Nonviral Causes of Liver Failure
    View official trial listing →
  • Completed NCT NCT00144703

    Sirolimus With Tacrolimus for Graft-vs-Host Disease Prophylaxis After Related Stem Cell Transplantation

    Not yet reported Dana-Farber Cancer Institute 55 participants Est. completion 2006-11 1 site
    Other conditions: Hematologic Malignancies, Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, Non-Hodgkin's Lymphoma, Hodgkin's Disease
    View official trial listing →
  • Completed NCT NCT00148746

    Standardized Time- and Score-oriented Treatment of Moderate and Severe Atopic Dermatitis

    Not yet reported Technische Universität Dresden Est. completion 2008-03 1 site
    Other conditions: Moderate to Severe Atopic Dermatitis
    View official trial listing →
  • Status unknown NCT NCT00166816

    The Pharmacokinetics of Sirolimus When Combined With Cyclosporine or Tacrolimus in Renal Transplant Patients

    Not yet reported National Taiwan University Hospital 40 participants Est. completion 2003-06 1 site
    Other conditions: Transplantation, Kidney Transplantation, Immunosuppression
    View official trial listing →
  • Status unknown NCT NCT00166829

    The Effect of Sirolimus on the Pharmacokinetics of Tacrolimus

    Not yet reported National Taiwan University Hospital 40 participants 1 site
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Status unknown NCT NCT00166842

    Sirolimus Blood Concentrations on Conversion From Oral Solution to Tablets

    Not yet reported National Taiwan University Hospital 40 participants 1 site
    Other conditions: Transplantation, Kidney Transplantation, Immunosuppression
    View official trial listing →
  • Completed NCT NCT00171743

    Efficacy and Safety of Cyclosporine Microemulsion in Diabetic Adult Stable Liver Transplant Recipients

    Not yet reported Novartis 47 participants Est. completion 2006-01
    Other conditions: Liver Transplant
    View official trial listing →
  • Completed NCT NCT00175253

    Alemtuzumab Induction in Islet Transplantation

    Not yet reported University of Alberta 12 participants Est. completion 2012-04 1 site
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT00177099

    Effects of Ligands on Human Hair Follicles Grafted Onto SCID Mice

    Not yet reported Hordinsky, Maria K., MD 35 participants Est. completion 2004-09 1 site
    Other conditions: Alopecia
    View official trial listing →
  • Completed NCT NCT00182559

    The Vienna Prograf and Endothelial Progenitor Cell Study

    Not yet reported Medical University of Vienna 148 participants Est. completion 2009-05 1 site
    Other conditions: End Stage Renal Disease
    View official trial listing →
  • Completed NCT NCT00189735

    A Study to Evaluate FK778 in Kidney Transplant Patients

    Not yet reported Astellas Pharma Inc 364 participants Est. completion 2005-10 37 sites
    Other conditions: Kidney Transplantation, Renal Transplantation, Transplantation, Renal, Transplantation, Kidney, Grafting, Kidney
    View official trial listing →
  • Completed NCT NCT00189826

    A Study to Evaluate the Safety and Efficacy of FK506E (MR4) in Patients Undergoing Primary Liver Transplantation.

    Not yet reported Astellas Pharma Inc 475 participants Est. completion 2006-12 51 sites Stand-alone
    Other conditions: Liver Transplantation
    View official trial listing →
  • Withdrawn NCT NCT00203281

    Study to Evaluate the Amount of Medications That May be Removed From the Body During Plasmapheresis

    Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University Est. completion 2009-09 2 sites
    Other conditions: Kidney Transplantation, Plasmapheresis
    View official trial listing →
  • Completed NCT NCT00214201

    Campath-1H Induction to Allow Discontinuation of Calcineurin Inhibitors After Renal Transplantation

    Not yet reported University of Wisconsin, Madison 40 participants Est. completion 2009-05 1 site Stand-alone
    Other conditions: Primary Renal Transplant
    View official trial listing →
  • Completed NCT NCT00214279

    MMF Monotherapy and Immune Regulation in Kidney Transplant Recipients: Part 1 Steroid Withdrawal

    Not yet reported University of Wisconsin, Madison 32 participants Est. completion 2007-11 1 site Stand-alone
    Other conditions: Renal Transplantation
    View official trial listing →
  • Completed NCT NCT00238979

    A Study to Investigate the Tolerability and Safety of Converting Stable Renal Transplant Recipients Who Receive Tacrolimus With or Without Corticosteroids From Mycophenolate Mofetil (MMF) to Enteric-coated Mycophenolate Sodium (EC-MPS)

    Not yet reported Novartis Pharmaceuticals 50 participants
    Other conditions: Renal Transplantation
    View official trial listing →
  • Completed NCT NCT00246129

    CamTac Trial:Campath-Tacrolimus vs IL2R MoAb/Tacrolimus/MMF in Renal Transplantation

    Not yet reported EMagnusson 123 participants Est. completion 2011-06 1 site Stand-alone
    Other conditions: Kidney Transplantation, Kidney Diseases, Kidney Failure
    View official trial listing →
  • Terminated NCT NCT00260208

    Liver Fibrosis in Patients Transplanted for Hepatitis C Receiving Either Cyclosporine Microemulsion or Tacrolimus

    Not yet reported Novartis Pharmaceuticals 361 participants 2 sites
    Other conditions: Liver Transplant, Hepatitis C
    View official trial listing →
  • Completed NCT NCT00267189

    RESCUE Study - Everolimus in Liver Transplantation Recipients With Renal Insufficiency

    Not yet reported Novartis Pharmaceuticals 145 participants Est. completion 2007-11 2 sites
    Other conditions: Liver Transplantation
    View official trial listing →
  • Completed NCT NCT00270634

    Study of ISA247 (Voclosporin) in De Novo Renal Transplantation

    Not yet reported Aurinia Pharmaceuticals Inc. 334 participants Est. completion 2009-07 45 sites
    Other conditions: Kidney Diseases
    View official trial listing →
  • Completed NCT NCT00275509

    Induction Therapy Study in Live Donor Kidney Transplant Recipients With a Positive Crossmatch

    Not yet reported Johns Hopkins University 56 participants Est. completion 2010-06 1 site Stand-alone
    Other conditions: Kidney Failure, Chronic
    View official trial listing →
  • Completed NCT NCT00282243

    A Study to Assess the Pharmacokinetics of a Modified-release Tacrolimus Based Immunosuppression Regimen in Stable Liver Transplant Patients

    Not yet reported Astellas Pharma Inc 70 participants Est. completion 2008-10 10 sites Stand-alone
    Other conditions: Liver Transplantation
    View official trial listing →
  • Completed NCT NCT00282282

    Tacrolimus and Sirolimus as Prophylaxis After Allogenic Non-myeloablative Peripheral Blood Stem Cell Transplantation

    Not yet reported Dana-Farber Cancer Institute 31 participants Est. completion 2009-07 1 site
    Other conditions: Graft Versus Host Disease, GVHD
    View official trial listing →
  • Completed NCT NCT00286871

    Randomized Controlled Trial in Liver Transplant Recipients Treated in Steroid Sparing Regimen

    Not yet reported Duke University 40 participants Est. completion 2009-02 1 site
    Other conditions: Chronic Hepatitis C, Organ Transplantation, Immunosuppression
    View official trial listing →
  • Status unknown NCT NCT00290069

    Renal Function Optimization With Mycophenolate Mofetil (MMF) Immunosuppressor Regimes (ALHAMBRA)

    Not yet reported Sociedad Andaluza de Trasplantes de Organos y Tejidos 94 participants 7 sites
    Other conditions: Kidney Diseases, Graft Rejection
    View official trial listing →
  • Completed NCT NCT00296023

    Donor Stem Cell Transplant in Treating Older or Frail Patients With Hematologic Cancer

    Not yet reported University of California, San Francisco 25 participants Est. completion 2008-06 2 sites Stand-alone
    Other conditions: Chronic Myeloproliferative Disorders, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes
    View official trial listing →
  • Completed NCT NCT00296361

    To Compare the Efficacy and Safety of a Therapy of Tacrolimus With Sirolimus or MMF in Kidney Transplantation.

    Not yet reported Astellas Pharma Inc 634 participants Est. completion 2006-07 59 sites Stand-alone
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT00297310

    Pre-transplant Assessment of Tacrolimus Blood Level Concentration, as a Predictor of Tacrolimus Dose Requirements After Kidney Transplantation

    Not yet reported Janssen-Cilag Pty Ltd 89 participants Est. completion 2007-04
    Other conditions: Kidney Transplantation, Transplantation
    View official trial listing →
  • Completed NCT NCT00297765

    Optimizing Prograf® Therapy in Renal Transplant Patients

    Not yet reported Astellas Pharma Inc 323 participants Est. completion 2006-03 42 sites
    Other conditions: Renal Transplantation
    View official trial listing →
  • Completed NCT NCT00298506

    Study to Assess the Efficacy and Safety of FK506 Combined With Mycophenolate Mofetil (MMF) in Lupus Nephritis (III/IV/V)

    Not yet reported Nanjing University School of Medicine 120 participants Est. completion 2009-06 2 sites
    Other conditions: Lupus Nephritis
    View official trial listing →
  • Completed NCT NCT00301951

    Low-Dose Fludarabine, Busulfan, and Anti-Thymocyte Globulin Followed By Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer

    Not yet reported University of California, San Francisco 7 participants Est. completion 2009-07 1 site Stand-alone
    Other conditions: Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes
    View official trial listing →
  • Withdrawn NCT NCT00302536

    Tacrolimus Treatment of Patients With Idiopathic Focal Segmental Glomerulosclerosis

    Not yet reported Nanjing University School of Medicine Est. completion 2010-09 1 site Stand-alone
    Other conditions: Focal Glomerulosclerosis
    View official trial listing →
  • Completed NCT NCT00304018

    Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer

    Not yet reported University of California, San Francisco 5 participants Est. completion 2009-03 1 site Stand-alone
    Other conditions: Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes
    View official trial listing →
  • Terminated NCT NCT00318110

    Matched Unrelated Donor Transplant for Metastatic Renal Cell Carcinoma

    Not yet reported Center for International Blood and Marrow Transplant Research 4 participants Est. completion 2009-03 5 sites Stand-alone
    Other conditions: Metastatic Renal Cell Carcinoma
    View official trial listing →
  • Completed NCT NCT00322101

    Low-Dose or High-Dose Conditioning Followed by Peripheral Blood Stem Cell Transplant in Treating Patients With Myelodysplastic Syndrome or Acute Myelogenous Leukemia

    Not yet reported Fred Hutchinson Cancer Center 25 participants Est. completion 2014-10 8 sites Stand-alone
    Other conditions: Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome, Acute Myeloid Leukemia/Transient Myeloproliferative Disorder, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Childhood Acute Myeloid Leukemia in Remission, Childhood Myelodysplastic Syndromes, de Novo Myelodysplastic Syndromes, Myelodysplastic Syndrome With Isolated Del(5q), Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable, Previously Treated Myelodysplastic Syndromes, Recurrent Adult Acute Myeloid Leukemia, Recurrent Childhood Acute Myeloid Leukemia, Secondary Acute Myeloid Leukemia, Secondary Myelodysplastic Syndromes
    View official trial listing →
  • Status unknown NCT NCT00325325

    Pharmacokinetic Study on the Combination of Everolimus-Tacrolimus

    Not yet reported Hospital Universitario Ramon y Cajal 40 participants Est. completion 2007-06 1 site
    Other conditions: Kidney Diseases
    View official trial listing →
  • Terminated NCT NCT00358657

    Fludarabine Phosphate, Cyclophosphamide, and Total-Body Irradiation Followed by Donor Bone Marrow Transplant and Cyclophosphamide, Mycophenolate Mofetil, Tacrolimus, and Sirolimus in Treating Patients With Primary Immunodeficiency Disorders or Noncancerous Inherited Disorders

    Not yet reported Fred Hutchinson Cancer Center 14 participants Est. completion 2019-05-25 3 sites Stand-alone
    Other conditions: Immunodeficiency Syndrome, Severe Aplastic Anemia, Genetic Disorder
    View official trial listing →
  • Completed NCT NCT00371319

    Comparing the Efficacy of Tacrolimus and Mycophenolate Mofetil for the Initial Therapy of Active Lupus Nephritis

    Not yet reported Tuen Mun Hospital 150 participants Est. completion 2014-06 1 site
    Other conditions: Lupus Nephritis
    View official trial listing →
  • Completed NCT NCT00374231

    Single Center Pilot Study of Corticosteroid Discontinuation in Liver Transplant Recipients

    Not yet reported University of Cincinnati 40 participants Est. completion 2008-01 1 site Stand-alone
    Other conditions: Liver Transplantation
    View official trial listing →
  • Completed NCT NCT00374803

    Study of Myfortic in Combination With Tacrolimus and Thymoglobulin in Early Corticosteroid Withdrawal

    Not yet reported University of Cincinnati 45 participants Est. completion 2008-01 2 sites
    Other conditions: End Stage Renal Disease (ESRD)
    View official trial listing →
  • Completed NCT NCT00384137

    A Conversion Study to Assess Safety and Efficacy of a MR4 Based Immunosuppressive Regimen in Stable Kidney Recipients

    Not yet reported Astellas Pharma Inc 128 participants Est. completion 2007-07 13 sites Stand-alone
    Other conditions: Transplantation
    View official trial listing →
  • Terminated NCT NCT00409461

    Comparison of Sirolimus Alone With Sirolimus Plus Tacrolimus in Type 1 Diabetic Recipients of Cultured Islet Cell Grafts

    Not yet reported Universitair Ziekenhuis Brussel 2 sites
    Other conditions: Islet Transplantation, Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT00411944

    Long-Term Pharmacokinetics of Tacrolimus in Renal Recipients

    KU Leuven 100 participants Est. completion 2005-09 1 site
    Other conditions: Renal Transplantation
    View official trial listing →
  • Completed NCT NCT00434850

    Peritransplant Deoxyspergualin in Islet Transplantation in Type 1 Diabetes

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 14 participants Est. completion 2013-11 3 sites Stand-alone
    Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Status unknown NCT NCT00443508

    Reduction or Discontinuation of CNI's With Conversion to Everolimus-Based Immunosuppresion

    Not yet reported Rabin Medical Center 60 participants Est. completion 2010-02 1 site
    Other conditions: Kidney Diseases
    View official trial listing →
  • Completed NCT NCT00446264

    Islet Allotransplantation With Steroid Free Immunosuppression

    Not yet reported University Hospital, Lille 14 participants Est. completion 2009-02 1 site Stand-alone
    Other conditions: Type 1 Diabetes, Hypoglycemia, Metabolic Diseases
    View official trial listing →
  • Completed NCT NCT00451932

    A Study to Evaluate the Safety and Effectiveness of FK778 in Liver Transplant Patients

    Not yet reported Astellas Pharma Inc 303 participants Est. completion 2005-09 29 sites
    Other conditions: Liver Transplantation
    View official trial listing →
  • Completed NCT NCT00456235

    Reduction in the Risk of Rejection by Mycophenolate Mofetil Dose Adjustment in Liver Transplant Patients With Side Effects Caused by the Calcineurine Inhibitors

    Not yet reported University Hospital, Limoges 92 participants Est. completion 2011-09 17 sites Stand-alone
    Other conditions: Liver Transplantation
    View official trial listing →
  • Completed NCT NCT00464555

    Strategies to Improve Islet Survival

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 5 participants Est. completion 2014-02 2 sites Stand-alone
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT00481481

    Conversion Study From Cyclosporine to FK506MR Based Immunosuppression in Kidney Transplant Subjects

    Not yet reported Astellas Pharma Inc 346 participants Est. completion 2009-04 56 sites Stand-alone
    Other conditions: Transplantation
    View official trial listing →
  • Completed NCT NCT00481819

    A Study to Compare the Efficacy and Safety of FK506MR vs Prograf® in Patients Undergoing Kidney Transplantation

    Not yet reported Astellas Pharma Inc 240 participants Est. completion 2009-03 9 sites
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Terminated NCT NCT00499889

    Imatinib Mesylate, Busulfan, Fludarabine, and Antithymocyte Globulin for CML Patients

    Not yet reported M.D. Anderson Cancer Center 42 participants Est. completion 2009-11 1 site Stand-alone
    Other conditions: Leukemia
    View official trial listing →
  • Completed NCT NCT00510913

    A Study to Compare the Conversion to Prograf® (Tacrolimus) to the Continuation of Cyclosporine in Patients at Risk for Chronic Renal Allograft Failure

    Not yet reported Astellas Pharma Inc 450 participants Est. completion 2000-09 18 sites
    Other conditions: Graft Rejection, Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT00518271

    Study Comparing Standard Dose and Reduced Dose Tacrolimus + Sirolimus + Corticosteroids in Renal Allograft Recipients

    Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 120 participants Est. completion 2002-06
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT00519116

    Study Comparing Standard Dose and Reduced Dose Tacrolimus With Sirolimus in Renal Transplant Patients

    Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 150 participants Est. completion 2001-08
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT00520130

    Chemotherapy and Unrelated Donor Stem Cell Transplantation for Patients With Cancers of the Blood and Immune System

    Not yet reported, Not yet reported National Cancer Institute (NCI) 92 participants Est. completion 2018-12-31 1 site Stand-alone
    Other conditions: Myelodysplastic Syndrome, Hodgkin's Lymphoma, Non-Hodgkin's Disease, Acute Leukemia, Multiple Myeloma
    View official trial listing →
  • Completed NCT NCT00525876

    Non-Myeloablative Allogeneic Stem Cell Transplantation

    Not yet reported M.D. Anderson Cancer Center 49 participants Est. completion 2010-09 1 site Stand-alone
    Other conditions: Lymphoma
    View official trial listing →
  • Completed NCT NCT00533442

    Rapamycin Versus Mycophenolate Mofetil in Kidney-Pancreas Recipients

    Not yet reported University of Miami 170 participants Est. completion 2016-05 1 site Stand-alone
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Active, not recruiting NCT NCT00544115

    Donor Peripheral Stem Cell Transplant in Treating Patients With Advanced Hematologic Cancer or Other Disorders

    Not yet reported City of Hope Medical Center 260 participants Est. completion 2027-03-29
    Other conditions: Chronic Myeloproliferative Disorders, Graft Versus Host Disease, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Diseases, Precancerous/Nonmalignant Condition
    View official trial listing →
  • Completed NCT NCT00545402

    A Study of CellCept (Mycophenolate Mofetil) in Combination Therapy in Liver Transplant Patients.

    Not yet reported Hoffmann-La Roche 180 participants Est. completion 2011-07 16 sites Stand-alone
    Other conditions: Liver Transplantation
    View official trial listing →
  • Terminated NCT NCT00555048

    Alemtuzumab, Busulfan, and Cyclophosphamide Followed By a Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer

    Not yet reported, Not yet reported Fred Hutchinson Cancer Center 1 participants 2 sites Stand-alone
    Other conditions: Graft Versus Host Disease, Leukemia, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Diseases
    View official trial listing →
  • Completed NCT NCT00556933

    Improved Induction and Maintenance Immunosuppression in Kidney Transplantation

    Not yet reported University of Nebraska 180 participants Est. completion 2011-06-01 1 site Stand-alone
    Other conditions: End-stage Renal Disease
    View official trial listing →
  • Terminated NCT NCT00579111

    Reduced Intensity Preparative Regimen Followed by Stem Cell Transplant (FAB)

    Not yet reported, Not yet reported Baylor College of Medicine 4 participants Est. completion 2010-10 2 sites
    Other conditions: Myelodysplastic and Myeloproliferative Disorders, Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, Multiple Myeloma, Plasma Cell Dyscrasia, Lymphoproliferative Disorders, Hematologic Diseases
    View official trial listing →
  • Completed NCT NCT00585468

    Pharmacokinetic Profile of Myfortic in Combination With Tacrolimus in Fed Versus Fasting State

    Not yet reported University of Utah 21 participants Est. completion 2011-07 1 site
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Terminated NCT NCT00589602

    T-Cell Depletion, Donor Hematopoietic Stem Cell Transplant (HSCT), and T-Cell Infusions in Treating Patients With Hematologic Cancer or Other Diseases

    Not yet reported The Cleveland Clinic 13 participants Est. completion 2014-12 1 site Stand-alone
    Other conditions: Chronic Myeloproliferative Disorders, Leukemia, Lymphoma, Multiple Myeloma and Malignant Plasma Cell Neoplasms, Myelodysplastic Syndromes, Precancerous/Nonmalignant Condition, Secondary Myelofibrosis
    View official trial listing →
  • Terminated NCT NCT00608517

    Treatment of Single or Double Umbilical Cord Trans + Graft-versus-host Disease (GVHD) Prophylaxis w/ Tacrolimus & Mycophenolate Mofetil

    Not yet reported Vanderbilt-Ingram Cancer Center 6 participants Est. completion 2011-05 4 sites
    Other conditions: Graft Versus Host Disease, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes
    View official trial listing →
  • Completed NCT NCT00611351

    Busulfan, Cyclophosphamide, & Antithymocyte Globulin Followed by Stem Cell Transplant in Treating Hematologic Cancer

    Not yet reported University of Nebraska 5 participants Est. completion 2008-09-17 1 site Stand-alone
    Other conditions: Graft Versus Host Disease, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Diseases, Secondary Myelofibrosis
    View official trial listing →
  • Completed NCT NCT00615173

    Prospective, Randomized, Multicenter, Control Study to Assess the Efficacy and Safety of Tacrolimus in Induction and Maintenance Phase Treatment in Lupus Nephritis

    Not yet reported Sun Yat-sen University 81 participants Est. completion 2008-09 1 site Stand-alone
    Other conditions: Kidney Diseases, Lupus Nephritis, Tacrolimus, Induction Phase, Maintenance Phase
    View official trial listing →
  • Terminated NCT NCT00623012

    Rapamycin for Prevention of Chronic Graft-Versus-Host Disease

    Not yet reported, Not yet reported Yale University 2 participants Est. completion 2013-08 1 site Stand-alone
    Other conditions: Graft Versus Host Disease
    View official trial listing →
  • Completed NCT NCT00637143

    Tacrolimus as Secondary Intervention vs. Continuation of Cyclosporine in Renal Transplant Patients With Chronic Renal Allograft Failure (CRAF)

    Not yet reported Astellas Pharma Inc 107 participants Est. completion 2006-02 13 sites Stand-alone
    Other conditions: Renal Transplantation, Chronic Renal Allograft Failure
    View official trial listing →
  • Completed NCT NCT00666302

    A Comparison Study Between Protopic (Tacrolimus) Ointment and Elidel (Pimecrolimus) Cream in Treating Subjects With Atopic Dermatitis

    Not yet reported Astellas Pharma Inc 413 participants Est. completion 2003-11 15 sites Stand-alone
    Other conditions: Dermatitis, Atopic
    View official trial listing →
  • Completed NCT NCT00667056

    Study of the Safety and Efficacy of Tacrolimus Ointment in Treating Chronic Allergic Contact Dermatitis

    Not yet reported Astellas Pharma Inc 98 participants Est. completion 2004-12 10 sites Stand-alone
    Other conditions: Dermatitis
    View official trial listing →
  • Completed NCT NCT00668369

    Effect of Immunosuppression Drug Weaning on Hepatitis C Virus (HCV)-Induced Liver Damage After Liver Transplantation

    Not yet reported Hospital Clinic of Barcelona 34 participants Est. completion 2011-09 1 site Stand-alone
    Other conditions: Hepatitis C Virus Infection, Liver Transplantation
    View official trial listing →
  • Completed NCT NCT00681213

    Tacrolimus/Sirolimus Versus Tacrolimus/Mycophenolate Mofetil (MMF) Versus Neoral/Sirolimus in Adult, Primary Kidney Transplantation

    Not yet reported University of Miami 150 participants Est. completion 2002-12 1 site Stand-alone
    Other conditions: Adult Primary Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT00691145

    Study to Evaluate the Efficacy and Safety of 0.1% and 0.03% Tacrolimus Ointment Administered in Adults With Moderate to Severe Atopic Dermatitis

    Not yet reported Astellas Pharma Inc 350 participants Est. completion 2005-02 26 sites Stand-alone
    Other conditions: Dermatitis, Atopic
    View official trial listing →
  • Completed NCT NCT00693381

    Mycophenolate Mofetil (MMF) Discontinuation From a Tacrolimus/MMF/Steroid Triple Regimen After Kidney Transplantation

    Not yet reported Astellas Pharma Inc 152 participants Est. completion 2004-08 14 sites Stand-alone
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT00693524

    Sequential Therapy (FK506 + Monoclonal Anti-IL2R Antibodies + MMF) Versus FK506 With Steroids in Liver TX

    Not yet reported Astellas Pharma Inc 94 participants Est. completion 2004-03 8 sites Stand-alone
    Other conditions: Liver Transplantation
    View official trial listing →
  • Terminated NCT NCT00694408

    A Pilot Trial of Pediatric Liver Transplantation Without Steroids

    Not yet reported Birmingham Women's and Children's NHS Foundation Trust 15 participants Est. completion 2011-08 1 site
    Other conditions: Evidence of Liver Transplantation
    View official trial listing →
  • Completed NCT NCT00707759

    Steroid Withdrawal in Pediatric Renal Transplant: Impact on Growth, Bone Metabolism and Acute Rejection

    Not yet reported Fondo Nacional de Desarrollo Científico y Tecnológico, Chile 28 participants Est. completion 2014-12 1 site Stand-alone
    Other conditions: Kidney Diseases
    View official trial listing →
  • Completed NCT NCT00716573

    Efficacy Study of Everolimus on Renal Function in Heart Transplant Recipients With Established Chronic Renal Failure

    Not yet reported Hospices Civils de Lyon 120 participants Est. completion 2014-04-17 1 site Stand-alone
    Other conditions: Cardiac Transplantation, Chronic Renal Insufficiency
    View official trial listing →
  • Completed NCT NCT00717379

    Study of Tacrolimus Immunosuppressive Therapy After Kidney Transplantation

    Not yet reported Astellas Pharma Inc 50 participants Est. completion 2008-10 6 sites Stand-alone
    Other conditions: Kidney Transplantation, Kidney Failure, Chronic, Renal Insufficiency, Chronic
    View official trial listing →
  • Completed NCT NCT00719745

    A Study to Assess the Safety and Efficacy of Prograf and MR4 in Liver Transplant Recipients

    Not yet reported Astellas Pharma Inc 74 participants Est. completion 2008-06 1 site
    Other conditions: Liver Transplantation
    View official trial listing →
  • Completed NCT NCT00729248

    The Differential Effects of 3 Different Immunosuppressive

    Northwestern University 12 participants Est. completion 2010-01 1 site
    Other conditions: Immunosuppression, Kidney Transplantation
    View official trial listing →
  • Terminated NCT NCT00731874

    Thymoglobulin Induction Therapy With Minimal Immunosuppression and Evaluation of Allograft Status

    Not yet reported Weill Medical College of Cornell University 34 participants Est. completion 2013-07 1 site
    Other conditions: Immunosuppression
    View official trial listing →
  • Status unknown NCT NCT00737659

    CellCept® Dose Adjustment Versus Fixed Dose (Standard Care) in Renal Transplant Recipients

    Not yet reported Rabin Medical Center 138 participants Est. completion 2013-08 2 sites
    Other conditions: Renal Transplant
    View official trial listing →
  • Completed NCT NCT00757874

    Tacrolimus Versus Clobetasol Propionate in the Treatment of Vulvar Lichen Sclerosus

    Not yet reported Deana Funaro 56 participants Est. completion 2010-01 1 site Stand-alone
    Other conditions: Vulvar Lichen Sclerosus
    View official trial listing →
  • Completed NCT NCT00762658

    A Phase I Study to Assess Novel Ointment in a Psoriasis Plaque Test

    Not yet reported Pfizer 12 participants Est. completion 2007-12-07 1 site
    Other conditions: Psoriasis
    View official trial listing →
  • Completed NCT NCT00772148

    Pharmacokinetics of LCP-Tacro™ Once Daily and Prograf® Twice A Day in Adult De Novo Liver Transplant Patients

    Not yet reported Veloxis Pharmaceuticals 58 participants Est. completion 2010-05 1 site Stand-alone
    Other conditions: Liver Failure
    View official trial listing →
  • Status unknown NCT NCT00780429

    Pharmacokinetics and Pharmacodynamics of MPA in Stable Renal Transplant Patients

    Fondazione IRCCS Policlinico San Matteo di Pavia 54 participants 1 site
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Withdrawn NCT NCT00790439

    Safety and Effectiveness of Low Molecular Weight Sulfated Dextran in Islet Transplantation After Kidney Transplant

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) Est. completion 2009-10 Stand-alone
    Other conditions: Diabetes Mellitus, Type I
    View official trial listing →
  • Terminated NCT NCT00801931

    Double Cord Blood Transplant for Patients With Malignant and Non-malignant Disorders

    Not yet reported, Not yet reported Columbia University 1 participants Est. completion 2009-05-05 1 site Stand-alone
    Other conditions: Leukemia, Lymphoma, Neuroblastoma, Immunodeficiencies, Anemia
    View official trial listing →
  • Terminated NCT NCT00811915

    Study to Compare the Safety and Efficacy of Sirolimus (Rapamune) to Tacrolimus (Advagraf) Associated to Mycophenolate Mofetil (CellCept) Between 12 and 36 Months After Kidney Transplantation

    Not yet reported University Hospital, Rouen 65 participants Est. completion 2014-06 8 sites Stand-alone
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT00812786

    Pharmacokinetics of Immunosuppressive Drugs in Heart Transplant Patients

    Not yet reported University Hospital, Limoges 42 participants Est. completion 2012-05 12 sites
    Other conditions: Heart Transplant
    View official trial listing →
  • Completed NCT NCT00821587

    Cyclosporine in Hepatitis C Infection Viral Clearance Following Liver Transplantation

    Not yet reported University of Florida 39 participants Est. completion 2008-05
    Other conditions: Hepatitis C
    View official trial listing →
  • Withdrawn NCT NCT00834496

    Switching From One Type of Anti-rejection Drug (Tacrolimus or Cyclosporine) to Another (Sirolimus) Approximately 90-180 Days After Liver Transplantation

    Thomas Jefferson University Est. completion 2010-01 1 site
    Other conditions: Side Effects of Calcineurin Inhibitors, Renal Toxicity, Hepatic Fibrosis on Biopsy, Neurotoxicity, Post Transplant Diabetes
    View official trial listing →
  • Withdrawn NCT NCT00853424

    A Comparison of Islet Cell Transplantation With Medical Therapy for the Treatment of Diabetic Eye Disease

    Not yet reported University of British Columbia Est. completion 2010-12 Stand-alone
    Other conditions: Diabetic Retinopathy, Diabetic Macular Edema
    View official trial listing →
  • Completed NCT NCT00865137

    An Open Study Assessing Bioavailability of a Modified Formulation of Tacrolimus in Kidney Transplant Recipients

    Not yet reported Astellas Pharma Inc 27 participants Est. completion 2007-12 1 site Stand-alone
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Active, not recruiting NCT NCT00882895

    Tandem Stem Cell Transplantation for Non-Hodgkin's Lymphoma

    Not yet reported Washington University School of Medicine 18 participants Est. completion 2028-06-01 1 site Stand-alone
    Other conditions: Lymphoma, Non-Hodgkin
    View official trial listing →
  • Completed NCT NCT00890500

    Safety and Efficacy of ProHema Modulated Umbilical Cord Blood Units in Subjects With Hematologic Malignancies.

    Not yet reported Fate Therapeutics 12 participants Est. completion 2013-10 2 sites
    Other conditions: Hematologic Malignancies, Allogeneic Stem Cell Transplantation
    View official trial listing →
  • Completed NCT NCT00896012

    Kidney Biopsy Controlled Trial of Calcineurin Inhibitor Withdrawal

    Not yet reported University at Buffalo 58 participants Est. completion 2011-12 1 site Stand-alone
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT00899847

    Phase 2 Study of Autologous Followed by Nonmyeloablative Allogeneic Transplantation Using TLI & ATG

    Not yet reported Stanford University 9 participants Est. completion 2014-12 1 site Stand-alone
    Other conditions: Transplantation, Homologous, Transplantation, Autologous, Multiple Myeloma, Blood and Marrow Transplant (BMT)
    View official trial listing →
  • Completed NCT NCT00902980

    Study of Immunosuppressive Therapy Toxicities in Kidney Transplant Recipients at Regional or Satellite Community Clinics

    Astellas Pharma Inc 264 participants Est. completion 2006-12 13 sites
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT00905515

    Optima: Optimizing Prograf Therapy in Maintenance Allografts II

    Not yet reported East Carolina University 63 participants Est. completion 2008-07 1 site
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT00912223

    Blood Stem Cell Transplant With Low Dose Chemotherapy for Relapsed Follicular Non-Hodgkin's Lymphoma (BMT CTN 0701)

    Not yet reported Medical College of Wisconsin 65 participants Est. completion 2016-08 21 sites Stand-alone
    Other conditions: Lymphoma, Non-Hodgkin
    View official trial listing →
  • Terminated NCT NCT00914940

    Selective Depletion of CD45RA+T Cells From Allogeneic Peripheral Blood Stem Cell Grafts for the Prevention of GVHD

    Not yet reported Fred Hutchinson Cancer Center 41 participants Est. completion 2020-05-26 2 sites Stand-alone
    Other conditions: Graft Versus Host Disease, Leukemia, Myelodysplastic Syndromes
    View official trial listing →
  • Terminated NCT NCT00934791

    Polycystic Liver Disease in Kidney Transplant

    Not yet reported Mayo Clinic 2 participants Est. completion 2012-12 1 site
    Other conditions: Polycystic Liver Disease
    View official trial listing →
  • Completed NCT NCT00941824

    Pharmacokinetic Evaluation of an Intensified and Decreasing Dosing Regimen of Mycophenolate Sodium in Combination With Tacrolimus Post Kidney Transplant: The Myfortic Study

    Not yet reported Centre Hospitalier Universitaire de Saint Etienne 15 participants Est. completion 2010-03 1 site
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Terminated NCT NCT00946023

    Optimized Donor Selection, Nonmyeloablative BMT for B-cell Lymphomas With Post-transplantation Cy and Rituximab

    Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 135 participants Est. completion 2013-07-17 1 site Stand-alone
    Other conditions: Lymphoma, B-cell Lymphoma, Non Hodgkin Lymphoma, Chronic Lymphocytic Leukemia
    View official trial listing →
  • Completed NCT NCT00948753

    Maraviroc in Patients Undergoing Non-Myeloablative Allogeneic Stem-Cell Transplantation

    Not yet reported, Not yet reported Abramson Cancer Center at Penn Medicine 38 participants Est. completion 2011-04 Stand-alone
    Other conditions: Graft-versus-host Disease, Hematopoietic Stem Cell Transplantation
    View official trial listing →
  • Withdrawn NCT NCT00972101

    Infusion of Expanded Cord Blood T Cells

    Not yet reported M.D. Anderson Cancer Center Est. completion 2011-09 Stand-alone
    Other conditions: Stem Cell Transplantation, Leukemia, Lymphoma, Pediatric Disorders
    View official trial listing →
  • Completed NCT NCT00982072

    Tacrolimus Versus Prednisolone for the Treatment of Minimal Change Disease

    Not yet reported Imperial College Healthcare NHS Trust 52 participants Est. completion 2019-10-10 1 site Stand-alone
    Other conditions: Minimal Change Disease
    View official trial listing →
  • Terminated NCT NCT00983645

    A Trial Comparing Prograf and Neoral Use in Kidney Transplant Recipients of Hispanic Ethnicity

    Not yet reported Loma Linda University 15 participants Est. completion 2013-03 1 site
    Other conditions: Renal Transplant Rejection
    View official trial listing →
  • Terminated NCT NCT01002339

    Optimum Immunosuppression in Renal Transplant Recipients.New Onset Diabetes After Transplantation

    Not yet reported Armando Torres Ramírez 134 participants Est. completion 2015-06 10 sites Stand-alone
    Other conditions: Diabetes Mellitus, Adult-Onset
    View official trial listing →
  • Terminated NCT NCT01005316

    Alloantibodies in Pediatric Heart Transplantation

    National Institute of Allergy and Infectious Diseases (NIAID) 290 participants Est. completion 2014-12 8 sites
    Other conditions: Pediatric Heart Transplantation, Pediatric Heart Transplant Recipients
    View official trial listing →
  • Completed NCT NCT01008462

    Autologous Peripheral Blood Stem Cell Transplant Followed by Donor Bone Marrow Transplant in Treating Patients With High-Risk Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Multiple Myeloma, or Chronic Lymphocytic Leukemia

    Not yet reported Fred Hutchinson Cancer Center 16 participants Est. completion 2018-06-30 2 sites Stand-alone
    Other conditions: B-Cell Prolymphocytic Leukemia, Hypodiploidy, Loss of Chromosome 17p, Plasma Cell Leukemia, Progression of Multiple Myeloma or Plasma Cell Leukemia, Recurrent Adult Hodgkin Lymphoma, Recurrent Adult Non-Hodgkin Lymphoma, Recurrent Childhood Hodgkin Lymphoma, Recurrent Childhood Non-Hodgkin Lymphoma, Recurrent Chronic Lymphocytic Leukemia, Recurrent Plasma Cell Myeloma, Recurrent Small Lymphocytic Lymphoma, Refractory Childhood Hodgkin Lymphoma, Refractory Chronic Lymphocytic Leukemia, Refractory Non-Hodgkin Lymphoma, Refractory Plasma Cell Myeloma, Refractory Small Lymphocytic Lymphoma, t(14;16), t(4;14), T-Cell Prolymphocytic Leukemia, Waldenstrom Macroglobulinemia
    View official trial listing →
  • Completed NCT NCT01010217

    Mismatched Transplantation Using High-dose Post-transplant Cyclophosphamide

    Not yet reported M.D. Anderson Cancer Center 176 participants Est. completion 2017-10-05 1 site Stand-alone
    Other conditions: Blood Stem Cell Transplant Failure, Leukemia, Hematologic Malignancies
    View official trial listing →
  • Completed NCT NCT01027000

    Donor Stem Cell Transplant in Treating Patients With High-Risk Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

    Not yet reported Alliance for Clinical Trials in Oncology 68 participants Est. completion 2023-04 25 sites Stand-alone
    Other conditions: Leukemia, Lymphoma
    View official trial listing →
  • Withdrawn NCT NCT01038505

    Comparison of Tacrolimus and Myfortic Versus Tacrolimus and Sirolimus

    Not yet reported University of Miami Est. completion 2013-01
    Other conditions: Living Donor Kidney Transplants Patients
    View official trial listing →
  • Withdrawn NCT NCT01047072

    Low-Dose Conditioning Followed by Donor Stem Cell Transplant in Treating Patients With Severe Systemic Sclerosis

    Not yet reported Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium 1 site Stand-alone
    Other conditions: Systemic Scleroderma
    View official trial listing →
  • Completed NCT NCT01056822

    Multicenter, Randomized, Open-label Study to Assess Whether Treatment With Mycophenolate Sodium (MPS) Allows Higher Dose Optimization Versus Mycophenolate Mofetil (MMF) Leading to a Dose Reduction of Tacrolimus. Maximiza Study.

    Not yet reported Novartis Pharmaceuticals 89 participants Est. completion 2013-04 19 sites
    Other conditions: Prophilaxis of Acute Rejection in Patients Receiving a Renal Allograft
    View official trial listing →
  • Completed NCT NCT01068054

    Efficacy Study of FK-506 and Cyclosporine in Vernal Keratoconjunctivits (VKC)

    Not yet reported, Not yet reported Siriraj Hospital 24 participants Est. completion 2005-05 1 site
    Other conditions: Keratoconjunctivitis, Vernal
    View official trial listing →
  • Completed NCT NCT01080534

    Bioequivalence Study of Tacrolimus 5 mg Capsule Under Fed Condition

    Not yet reported Panacea Biotec Ltd 36 participants Est. completion 2007-10 1 site Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT01106833

    Chronic Graft-versus-Host Disease Treatment (BMT CTN 0801)

    Not yet reported, Not yet reported Medical College of Wisconsin 151 participants Est. completion 2018-06 31 sites
    Other conditions: Chronic GVHD
    View official trial listing →
  • Terminated NCT NCT01116232

    Sirolimus, Tacrolimus, Thymoglobulin and Rituximab as Graft-versus-Host-Disease Prophylaxis in Patients Undergoing Haploidentical and HLA Partially Matched Donor Hematopoietic Cell Transplantation

    Not yet reported Barbara Ann Karmanos Cancer Institute 4 participants Est. completion 2013-06 1 site Stand-alone
    Other conditions: Chronic Myeloproliferative Disorders, Graft Versus Host Disease, Leukemia, Lymphoma, Lymphoproliferative Disorder, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
    View official trial listing →
  • Completed NCT NCT01120028

    Campath, Calcineurin Inhibitor Reduction and Chronic Allograft Nephropathy

    Not yet reported, Not yet reported University of Oxford 852 participants Est. completion 2020-03 20 sites Stand-alone
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Terminated NCT NCT01122719

    Brazilian and Italian Evaluation of Safety Using Tacrolimus-eluting Stent With Short-term Dual Antiplatelet Regimen

    Not yet reported CID - Carbostent & Implantable Devices 16 participants Est. completion 2013-03 2 sites
    Other conditions: Stable Coronary Disease, Unstable Coronary Disease, Documented Silent Ischemia
    View official trial listing →
  • Completed NCT NCT01126333

    Long-term Follow-up of Spare the Nephron (STN) Patients

    University of Maryland, Baltimore 128 participants Est. completion 2015-06-30 1 site
    Other conditions: Kidney Transplant
    View official trial listing →
  • Completed NCT NCT01137084

    Liver Transplantation Results in Hepatocellular Carcinoma Patients With Immunosuppression Without Steroids

    Not yet reported Shanghai Jiao Tong University School of Medicine 300 participants Est. completion 2009-12 1 site
    Other conditions: Immunosuppression, Hepatocellular Carcinoma, Liver Transplantation, Post-operative Complications
    View official trial listing →
  • Completed NCT NCT01163357

    Bortezomib, Total Marrow Irradiation, Fludarabine Phosphate, and Melphalan in Treating Patients Undergoing Donor Peripheral Blood Stem Cell Transplant For High-Risk Stage I or II Multiple Myeloma

    Not yet reported City of Hope Medical Center 18 participants Est. completion 2024-05-20 1 site Stand-alone
    Other conditions: Autologous Hematopoietic Stem Cell Transplant Recipient, Loss of Chromosome 17p, Plasma Cell Leukemia, Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma
    View official trial listing →
  • Completed NCT NCT01183247

    An Open, Single Centre, Randomised, Parallel Group Study to Investigate Three Different Immunosuppressive Regimens

    Not yet reported University Hospital, Basel, Switzerland 63 participants Est. completion 2010-06 1 site
    Other conditions: Comparative Study, Immunosuppressive Agents
    View official trial listing →
  • Completed NCT NCT01188798

    Methotrexate or Pentostatin for Graft-versus-host Disease Prophylaxis in Risk-adapted Allogeneic Bone Marrow Transplantation for Hematologic Malignancies

    Not yet reported St. Jude Children's Research Hospital 6 participants Est. completion 2012-02 1 site
    Other conditions: Acute Lymphoblastic Leukemia, Acute Myelocytic Leukemia, Chronic Myelocytic Leukemia, Hodgkin's Disease, Myelodysplastic Syndrome
    View official trial listing →
  • Completed NCT NCT01208896

    Allogeneic Hematopoietic Stem Cell Transplantation After Reduced-intensity Conditioning for Relapsed Follicular Lymphoma

    Not yet reported University Hospital, Bordeaux 32 participants Est. completion 2017-09-28 26 sites Stand-alone
    Other conditions: Lymphoma, Follicular, Stem Cell Transplantation
    View official trial listing →
  • Completed NCT NCT01222039

    Multicenter Clinical Trial for the Evaluation of Mesenchymal Stem Cells From Adipose Tissue in Patients With Chronic Graft Versus Host Disease.

    Not yet reported, Not yet reported Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud 19 participants Est. completion 2014-06 4 sites Stand-alone
    Other conditions: Graft Versus Host Disease, Chronic and Expanded Graft Versus Host Disease, Immune System Diseases
    View official trial listing →
  • Completed NCT NCT01233570

    Topical Tacrolimus 0.1% Ointment For Treatment Of Cutaneous Crohn's Disease

    Not yet reported University of Aberdeen 20 participants 1 site Stand-alone
    Other conditions: Crohn Disease
    View official trial listing →
  • Completed NCT NCT01256294

    Pharmacokinetics of Generic to Brand Tacrolimus in Stable Renal Transplant Patients

    Not yet reported Novartis 71 participants Est. completion 2011-05 2 sites Stand-alone
    Other conditions: Renal Transplant
    View official trial listing →
  • Completed NCT NCT01256398

    Dasatinib Followed by Stem Cell Transplant in Treating Older Patients With Newly Diagnosed Acute Lymphoblastic Leukemia

    Not yet reported National Cancer Institute (NCI) 66 participants Est. completion 2021-11-15 101 sites Stand-alone
    Other conditions: Acute Lymphoblastic Leukemia, Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1
    View official trial listing →
  • Terminated NCT NCT01268995

    Improving Secretion of Insulin in New Onset Diabetes After Renal Transplantation

    Not yet reported Medical University of Vienna 32 participants Est. completion 2010-12 1 site Stand-alone
    Other conditions: New Onset Diabetes Mellitus After Renal Transplantation
    View official trial listing →
  • Withdrawn NCT NCT01269684

    Immediate Conversion From Tacrolimus to Everolimus in Stable Maintenance Renal Transplant Recipients

    Not yet reported Novartis Pharmaceuticals Est. completion 2008-08 1 site
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Terminated NCT NCT01303965

    Allo Transplant Followed by Lenalidomide and Sirolimus Maintenance in High-Risk Multiple Myeloma (MM)

    Not yet reported, Not yet reported Sherif S. Farag 14 participants Est. completion 2017-07-28 1 site Stand-alone
    Other conditions: Multiple Myeloma
    View official trial listing →
  • Completed NCT NCT01304836

    A Study Looking at Diabetes in Kidney Transplant Recipients Receiving Immunosuppressive Regimen With or Without Steroids

    Not yet reported Astellas Pharma Inc 1166 participants Est. completion 2013-05-22 100 sites
    Other conditions: Kidney Transplantation
    View official trial listing →
  • No Longer Available NCT NCT01309022

    Immunosuppressive Medications for Participants in ITN005CT (NCT00014911)

    National Institute of Allergy and Infectious Diseases (NIAID) 3 sites
    Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT01309477

    The Efficacy and Tolerance of Tacrolimus Sustained-release Capsules on Refractory Nephrotic Syndrome (RNS)

    Not yet reported Sun Yat-sen University 20 participants Est. completion 2011-10 1 site Stand-alone
    Other conditions: Nephrotic Syndrome
    View official trial listing →
  • Completed NCT NCT01332201

    Study to Compare the Pharmacokinetics of Tacrolimus in Adult Transplant Recipients Treated With Advagraf® or Prograf®

    Not yet reported Astellas Pharma Inc 17 participants Est. completion 2013-11 8 sites
    Other conditions: Heart Transplantation, Lung Transplantation, Pancreas (Including SPK) Transplantation
    View official trial listing →
  • Completed NCT NCT01342289

    Shorter Course Tacrolimus After Nonmyeloablative, Related Donor BMT With High-dose Posttransplantation Cyclophosphamide

    Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 127 participants Est. completion 2018-03 1 site Stand-alone
    Other conditions: Hodgkin's Lymphoma, Leukemia, Myelodysplastic Syndrome(MDS), Multiple Myeloma, Non Hodgkin's Lymphoma
    View official trial listing →
  • Completed NCT NCT01346397

    Study Cyclosporine (CsA) Versus Tacrolimus (Tacro) After Campath Induction in Kidney Transplantation

    Russian Academy of Medical Sciences 170 participants Est. completion 2016-05 1 site
    Other conditions: Acute Graft Rejection, Chronic Allograft Nephropathy, Polyomavirus-related Transplant Nephropathy
    View official trial listing →
  • Completed NCT NCT01354301

    Efficacy and Safety of Induction Strategies Combined With Low Tacrolimus Exposure in Kidney Transplant Recipients Receiving Everolimus or Sodium Mycophenolate

    Not yet reported Hospital do Rim e Hipertensão 300 participants Est. completion 2014-12 1 site Stand-alone
    Other conditions: Cytomegalovirus Infection, Renal Transplant Failure, Transplant; Complication, Rejection
    View official trial listing →
  • Completed NCT NCT01380535

    Extracorporeal Photopheresis (ECP) With Methoxsalen for Chronic Graft Versus Host Disease (cGVHD)

    Not yet reported Mallinckrodt 60 participants Est. completion 2015-03 32 sites Stand-alone
    Other conditions: Chronic Graft Versus Host Disease
    View official trial listing →
  • Status unknown NCT NCT01399242

    Efficacy of Certican® in Combination With Myfortic® in Renal

    Not yet reported Hospital Universitário São José 40 participants Est. completion 2013-06 1 site
    Other conditions: Disorder Related to Renal Transplantation
    View official trial listing →
  • Completed NCT NCT01410162

    Advagraf/Prograf Conversion Trial

    Not yet reported Norman Muirhead 53 participants Est. completion 2014-12 1 site
    Other conditions: Renal Transplant, Kidney Pancreas Transplant
    View official trial listing →
  • Completed NCT NCT01418131

    Rectal Tacrolimus in the Treatment of Resistant Ulcerative Proctitis

    Not yet reported The University of Western Australia 21 participants Est. completion 2016-11 4 sites
    Other conditions: Ulcerative Colitis
    View official trial listing →
  • Completed NCT NCT01429844

    Tacrolimus Versus Cyclosporine for Immunosuppression After Lung Transplantation

    Not yet reported Universitätsklinikum Hamburg-Eppendorf 274 participants Est. completion 2010-08 14 sites
    Other conditions: Bronchiolitis Obliterans, Immunosuppression
    View official trial listing →
  • Terminated NCT NCT01436305

    Optimization of NULOJIX® Usage As A Means of Avoiding CNI and Steroids in Renal Transplantation

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 19 participants Est. completion 2015-04 3 sites Stand-alone
    Other conditions: Kidney Transplantation, Renal Transplantation
    View official trial listing →
  • Terminated NCT NCT01445236

    Pilot Study of Immunosuppression Drug Weaning in Liver Recipients Exhibiting Biomarkers of High Likelihood of Tolerance

    Not yet reported Hospital Clinic of Barcelona 25 participants Est. completion 2013-01 1 site
    Other conditions: Liver Transplantation
    View official trial listing →
  • Status unknown NCT NCT01446484

    Treatment of Children With Kidney Transplants by Injection of CD4+CD25+FoxP3+ T Cells to Prevent Organ Rejection

    Not yet reported, Not yet reported Pirogov Russian National Research Medical University 30 participants Est. completion 2014-11 2 sites Stand-alone
    Other conditions: End-Stage Renal Disease, Kidney Failure
    View official trial listing →
  • Completed NCT NCT01471444

    Fludarabine-IV Busulfan ± Clofarabine and Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)

    Not yet reported M.D. Anderson Cancer Center 256 participants Est. completion 2020-12-14 1 site Stand-alone
    Other conditions: Disorder Related to Bone Marrow Transplantation, Leukemia, Transplantation Infection
    View official trial listing →
  • Completed NCT NCT01491958

    Safety & Efficacy of Atorvastatin for Prophylaxis of Acute Graft Versus Host Disease in Patients With Hematological Malignancies HLA- Donor Hematopoietic Stem Cell Transplantation

    Not yet reported Ohio State University Comprehensive Cancer Center 40 participants Est. completion 2016-06-27 1 site Stand-alone
    Other conditions: Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, Myelodysplastic Syndrome
    View official trial listing →
  • Completed NCT NCT01511003

    A Study is to Assess Efficacy and Safety of Tacrolimus in Active Rheumatoid Arthritis Patients Who Showed Unsuccessful Response to Existing Disease Modifying Antirheumatic Drugs (DMARDs)

    Not yet reported Astellas Pharma Inc 128 participants Est. completion 2015-05-11 4 sites Stand-alone
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Terminated NCT NCT01518153

    Planned Donor Lymphocyte Infusion (DLI) After Allogeneic Stem Cell Transplantation (SCT)

    Not yet reported M.D. Anderson Cancer Center 16 participants Est. completion 2014-08 1 site Stand-alone
    Other conditions: Leukemia, Lymphoma, Myeloma, Myeloproliferative Diseases
    View official trial listing →
  • Completed NCT NCT01529827

    Fludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies

    Not yet reported Roswell Park Cancer Institute 94 participants Est. completion 2019-08-29 1 site Stand-alone
    Obstructive sleep apnea Other conditions: Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Adult Grade III Lymphomatoid Granulomatosis, Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, Aplastic Anemia, Burkitt Lymphoma, Childhood Acute Lymphoblastic Leukemia in Remission, Childhood Acute Myeloid Leukemia in Remission, Childhood Chronic Myelogenous Leukemia, Childhood Diffuse Large Cell Lymphoma, Childhood Grade III Lymphomatoid Granulomatosis, Childhood Immunoblastic Large Cell Lymphoma, Childhood Myelodysplastic Syndromes, Childhood Nasal Type Extranodal NK/T-cell Lymphoma, Chronic Myelomonocytic Leukemia, Chronic Phase Chronic Myelogenous Leukemia, Congenital Amegakaryocytic Thrombocytopenia, Diamond-Blackfan Anemia, Hepatosplenic T-cell Lymphoma, Juvenile Myelomonocytic Leukemia, Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable, Nodal Marginal Zone B-cell Lymphoma, Paroxysmal Nocturnal Hemoglobinuria, Peripheral T-cell Lymphoma, Polycythemia Vera, Post-transplant Lymphoproliferative Disorder, Previously Treated Myelodysplastic Syndromes, Primary Myelofibrosis, Recurrent Adult Acute Lymphoblastic Leukemia, Recurrent Adult Acute Myeloid Leukemia, Recurrent Adult Burkitt Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma, Recurrent Adult Diffuse Mixed Cell Lymphoma, Recurrent Adult Diffuse Small Cleaved Cell Lymphoma, Recurrent Adult Grade III Lymphomatoid Granulomatosis, Recurrent Adult Hodgkin Lymphoma, Recurrent Adult Immunoblastic Large Cell Lymphoma, Recurrent Adult Lymphoblastic Lymphoma, Recurrent Adult T-cell Leukemia/Lymphoma, Recurrent Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood Acute Myeloid Leukemia, Recurrent Childhood Anaplastic Large Cell Lymphoma, Recurrent Childhood Grade III Lymphomatoid Granulomatosis, Recurrent Childhood Large Cell Lymphoma, Recurrent Childhood Lymphoblastic Lymphoma, Recurrent Childhood Small Noncleaved Cell Lymphoma, Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Grade 3 Follicular Lymphoma, Recurrent Mantle Cell Lymphoma, Recurrent Marginal Zone Lymphoma, Recurrent Mycosis Fungoides/Sezary Syndrome, Recurrent Small Lymphocytic Lymphoma, Recurrent/Refractory Childhood Hodgkin Lymphoma, Refractory Chronic Lymphocytic Leukemia, Refractory Hairy Cell Leukemia, Refractory Multiple Myeloma, Secondary Acute Myeloid Leukemia, Secondary Myelodysplastic Syndromes, Secondary Myelofibrosis, Severe Combined Immunodeficiency, Severe Congenital Neutropenia, Shwachman-Diamond Syndrome, Splenic Marginal Zone Lymphoma, T-cell Large Granular Lymphocyte Leukemia, Waldenstrom Macroglobulinemia, Wiskott-Aldrich Syndrome
    View official trial listing →
  • Terminated NCT NCT01534143

    High Dose Busulfan and Bortezomib in Treating Patients With High Risk Multiple Myeloma Undergoing Stem Cell Transplant

    Not yet reported Barbara Ann Karmanos Cancer Institute 1 participants Est. completion 2013-05 1 site Stand-alone
    Other conditions: Refractory Multiple Myeloma, Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma
    View official trial listing →
  • Completed NCT NCT01536535

    Predicting Response to Standardized Pediatric Colitis Therapy

    Not yet reported Connecticut Children's Medical Center 431 participants Est. completion 2018-04-30 29 sites Stand-alone
    Other conditions: Ulcerative Colitis
    View official trial listing →
  • Completed NCT NCT01541384

    Medication Adherence in Kidney Transplant Recipients Using Automated Reminders and Provider Notification

    Not yet reported University of Pennsylvania 120 participants Est. completion 2015-09 1 site Stand-alone
    Other conditions: Medication Adherence
    View official trial listing →
  • Completed NCT NCT01544491

    Efficacy, Tolerability and Safety of Early Introduction of Everolimus, Reduced Calcineurin Inhibitors and Early Steroid Elimination Compared to Standard CNI, Mycophenolate Mofetil and Steroid Regimen in Paediatric Renal Transplant Recipients

    Not yet reported Novartis Pharmaceuticals 106 participants Est. completion 2018-09-24 31 sites Stand-alone
    Other conditions: Prevention of Acute Rejection in Paediatric Recipients of a Renal Transplant
    View official trial listing →
  • Status unknown NCT NCT01550445

    Steroid Withdrawal Immunosuppression After Renal Transplantation

    Not yet reported Ajou University School of Medicine 30 participants Est. completion 2012-07 1 site
    Other conditions: Disorder Related to Renal Transplantation
    View official trial listing →
  • Terminated NCT NCT01561404

    Effect of the Inhibition of the Mammalian Target of Rapamycin on Metabolism and Exercise

    Not yet reported Josep M Cruzado 3 participants Est. completion 2013-12 1 site Stand-alone
    Other conditions: Disorder Related to Renal Transplantation, Exercise, Aerobic, Muscle Strength
    View official trial listing →
  • Terminated NCT NCT01570348

    Crohn's Allogeneic Transplant Study

    Not yet reported Fred Hutchinson Cancer Center 2 participants Est. completion 2019-10-30 1 site Stand-alone
    Other conditions: Crohn Disease
    View official trial listing →
  • Completed NCT NCT01597778

    Double Cord Versus Haploidentical (BMT CTN 1101)

    Not yet reported Medical College of Wisconsin 368 participants Est. completion 2020-09-11 39 sites Stand-alone
    Other conditions: Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Burkitt's Lymphoma, Follicular Lymphoma, Hodgkin Lymphoma, Mantle Cell Lymphoma, Non-Hodgkin Lymphoma
    View official trial listing →
  • Completed NCT NCT01598987

    Efficacy, Safety and Tolerability of Everolimus in Combination With Reduced Exposure Cyclosporine or Tacrolimus in Paediatric Liver Transplant Recipients.

    Not yet reported Novartis Pharmaceuticals 56 participants Est. completion 2016-06 32 sites Stand-alone
    Other conditions: Renal Function, Liver Transplant
    View official trial listing →
  • Status unknown NCT NCT01608412

    A Clinical Trial to Assess the Efficacy and Safety of the Conversion to Everolimus

    Not yet reported Hospital de Clinicas de Porto Alegre 120 participants Est. completion 2014-07 1 site
    Other conditions: Kidney Transplant Recipients
    View official trial listing →
  • Completed NCT NCT01614665

    A Study to Compare How the Body Absorbs and Processes Two Different Formulations of the Anti-rejection Medication Tacrolimus (Advagraf® or Prograf®) in Children Receiving an Organ Transplant, and How Safe and Effective They Are Over a Longer Period of Time

    Not yet reported Astellas Pharma Europe Ltd. 44 participants Est. completion 2021-04-21 10 sites Stand-alone
    Other conditions: Heart Transplantation, Kidney Transplantation, Liver Transplantation
    View official trial listing →
  • Terminated NCT NCT01621477

    T-Cell Replete Haploidentical Donor Hematopoietic Stem Cell Plus Natural Killer (NK) Cell Transplantation in Patients With Hematologic Malignancies Relapsed or Refractory Despite Previous Allogeneic Transplant

    Not yet reported St. Jude Children's Research Hospital 34 participants Est. completion 2015-12 1 site Stand-alone
    Other conditions: Acute Lymphoblastic Leukemia, Acute Myelocytic Leukemia, Chronic Myelocytic Leukemia, Juvenile Myelomonocytic Leukemia, Myelodysplastic Syndrome, Hodgkin or Non-Hodgkin Lymphoma, Sarcoma, Myeloid
    View official trial listing →
  • Completed NCT NCT01625377

    A National Multi-center Randomized, Open Label Study to Evaluate Efficacy and Safety of Everolimus With EC-MPS Compared to Standard Treatment Combination Tacrolimus and EC-MPS in de Novo Liver Transplant Recipients

    Not yet reported Novartis Pharmaceuticals 188 participants Est. completion 2015-03 14 sites Stand-alone
    Other conditions: Liver Transplantation
    View official trial listing →
  • Terminated NCT NCT01629511

    Allogeneic Stem Cell Transplant for CLL

    Not yet reported, Not yet reported M.D. Anderson Cancer Center 15 participants Est. completion 2018-04-25 1 site Stand-alone
    Other conditions: Allogeneic Hematopoietic Stem Cell Transplantation Recipient, Chronic Lymphocytic Leukemia, Prolymphocytic Leukemia, Richter Syndrome
    View official trial listing →
  • Status unknown NCT NCT01631058

    Renal Transplantation in the Elderly - nEverOld Study

    Not yet reported University of Sao Paulo General Hospital 90 participants Est. completion 2019-06 2 sites Stand-alone
    Other conditions: Chronic Renal Failure (CRF), Graft Failure, Transplant; Failure, Kidney, Renal Transplant Rejection
    View official trial listing →
  • Completed NCT NCT01647945

    FK506 (Tacrolimus) in Pulmonary Arterial Hypertension

    Not yet reported Edda Spiekerkoetter 23 participants Est. completion 2014-08 1 site
    Other conditions: Pulmonary Arterial Hypertension
    View official trial listing →
  • Completed NCT NCT01655563

    Pharmacogenetic Trial of Tacrolimus After Pediatric Transplantation

    Not yet reported The Hospital for Sick Children 75 participants Est. completion 2016-02 1 site Stand-alone
    Other conditions: Heart Transplantation, Liver Transplantation, Kidney Transplantation
    View official trial listing →
  • Terminated NCT NCT01663766

    Phase I Study of Milatuzumab for Graft Versus Host Disease

    Not yet reported Gilead Sciences 12 participants Est. completion 2015-03 1 site Stand-alone
    Other conditions: GVHD (Acute or Chronic), Acute Myeloid or Lymphoblastic Leukemia (AML or ALL), Myelodysplastic Syndrome, Chronic Myelogenous Leukemia (CML), Multiple Myeloma (MM), Non-Hodgekin Lymphoma (NHL-both Follicular & Diffuse Large Cell), Chronic Lymphocytic Leukemia or Small Lymphocytic Leukemia (CLL or SLL)
    View official trial listing →
  • Completed NCT NCT01664910

    CMC-544 and Allogeneic Transplantation for CD22 Positive-Lymphoid Malignancies

    Not yet reported, Not yet reported M.D. Anderson Cancer Center 27 participants Est. completion 2023-06-28 1 site Stand-alone
    Other conditions: Hematopoietic and Lymphoid Cell Neoplasm
    View official trial listing →
  • Terminated NCT NCT01685411

    Busulfan and Cyclophosphamide Followed By ALLO BMT

    Not yet reported Masonic Cancer Center, University of Minnesota 5 participants Est. completion 2020-02-10 1 site Stand-alone
    Other conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Myelodysplastic Syndrome
    View official trial listing →
  • Completed NCT NCT01698541

    Generic Tacrolimus in the Elderly - Prograf® vs Tacni®

    Not yet reported University of Oslo School of Pharmacy 28 participants Est. completion 2013-11 1 site Stand-alone
    Other conditions: End Stage Renal Disease
    View official trial listing →
  • Status unknown NCT NCT01699360

    The Biomarker for Immunosuppressive Agents Metabolism in Chinese Renal Transplant Recipients

    Not yet reported Central South University 600 participants Est. completion 2013-12 1 site Stand-alone
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT01702207

    Evaluation Of Switching From Twice Daily Tacrolimus To Once Daily Formulation On Cardiovascular Risk

    Not yet reported University of Saskatchewan 36 participants Est. completion 2017-12 1 site
    Cardiovascular disease Other conditions: Immunosuppression, Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT01707004

    Decitabine and Total-Body Irradiation Followed By Donor Bone Marrow Transplant and Cyclophosphamide in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

    Not yet reported University of Wisconsin, Madison 20 participants Est. completion 2017-10-07 1 site Stand-alone
    Other conditions: Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), de Novo Myelodysplastic Syndromes, Previously Treated Myelodysplastic Syndromes, Recurrent Adult Acute Myeloid Leukemia, Secondary Acute Myeloid Leukemia
    View official trial listing →
  • Completed NCT NCT01729494

    Belatacept Early Steroid Withdrawal Trial

    Not yet reported University of Cincinnati 316 participants Est. completion 2019-12 8 sites
    Other conditions: Renal Transplantation
    View official trial listing →
  • Completed NCT NCT01743131

    Abatacept as GVHD Prophylaxis Phase 2

    Not yet reported Boston Children's Hospital 186 participants Est. completion 2024-03-30 14 sites Stand-alone
    Other conditions: Graft vs Host Disease, Malignancy
    View official trial listing →
  • Completed NCT NCT01744067

    The Effects of Omega-3 Fatty Acids in Renal Transplantation

    Not yet reported Oslo University Hospital 132 participants Est. completion 2015-12 2 sites
    Other conditions: Disorder Related to Renal Transplantation
    View official trial listing →
  • Status unknown NCT NCT01744470

    Efficacy and Safety Study of a 4-Month Post-Renal Transplant Dose Reduction of Tacrolimus(ADEQUATE)

    Not yet reported University Hospital, Tours 286 participants Est. completion 2015-03 16 sites Stand-alone
    Other conditions: De Novo Transplant Disease
    View official trial listing →
  • Terminated NCT NCT01749111

    Comparison Between Cyclophosphamide and Combination of Methotrexate + Calcineurin Inhibitor for GVHD Prophylaxis

    Not yet reported Hospital Israelita Albert Einstein 3 participants Est. completion 2016-08 1 site
    Other conditions: Acute Myelogenous Leukemia, Acute Lymphoid Leukemia, Myeloproliferative Disease, Myelodysplastic Syndrome, Chronic Myeloid Leukemia, Chronic Myelomonocytic Leukemia
    View official trial listing →
  • Completed NCT NCT01760655

    Reduced-Intensity Conditioning Before Donor Stem Cell Transplant in With High-Risk Hematologic Malignancies

    Not yet reported Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 62 participants Est. completion 2022-12-05 1 site Stand-alone
    Other conditions: Acute Myeloid Leukemia With FLT3/ITD Mutation, Acute Myeloid Leukemia With Gene Mutations, Acute Myeloid Leukemia With Inv(3) (q21.3;q26.2); GATA2, MECOM, Acute Myeloid Leukemia With t(6;9) (p23;q34.1); DEK-NUP214, Aplastic Anemia, Chronic Lymphocytic Leukemia, Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Chronic Myelomonocytic Leukemia, Follicular Lymphoma, Hodgkin Lymphoma, Myelodysplastic Syndrome, Myelofibrosis, Myeloid Leukemia, Non-Hodgkin Lymphoma, Plasma Cell Myeloma, Polycythemia Vera, Recurrent Adult Acute Myeloid Leukemia, Recurrent Childhood Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia, Secondary Acute Myeloid Leukemia, Therapy-Related Acute Myeloid Leukemia
    View official trial listing →
  • Completed NCT NCT01768845

    Unrelated Umbilical Cord Blood (UBC)Transplantation

    Not yet reported West Virginia University 34 participants Est. completion 2021-04-06 1 site Stand-alone
    Other conditions: Chronic Myelogenous Leukemia (CML), Acute Myelogenous Leukemia (AML), Myelodysplastic Syndrome, Multiple Myeloma, Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia (CLL), Acute Lymphocytic Leukemia (ALL), Severe Aplastic Anemia
    View official trial listing →
  • Completed NCT NCT01771705

    NFAT-Dependent Cytokine Gene Expression for Immune Monitoring in Kidney Transplant Patients

    Not yet reported University of California, San Francisco 40 participants Est. completion 2017-04-17 1 site
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Terminated NCT NCT01773395

    GVAX vs. Placebo for MDS/AML After Allo HSCT

    Not yet reported Dana-Farber Cancer Institute 123 participants Est. completion 2021-11-24 4 sites
    Other conditions: Myelodysplastic Syndrome, Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia
    View official trial listing →
  • Completed NCT NCT01785810

    Phase II Maraviroc for GVHD Prevention

    Not yet reported Abramson Cancer Center at Penn Medicine 37 participants Est. completion 2018-07-12 1 site Stand-alone
    Other conditions: Hematologic Malignancy
    View official trial listing →
  • Completed NCT NCT01788501

    Tacrolimus/Methotrexate Versus Cyclosporine/Methotrexate for Prophylaxis of Graft Versus Host Disease

    Not yet reported, Not yet reported Seoul National University Hospital 50 participants Est. completion 2017-03-01 3 sites Stand-alone
    Other conditions: Graft vs Host Disease
    View official trial listing →
  • Completed NCT NCT01789255

    Vorinostat, Tacrolimus, and Methotrexate in Preventing GVHD After Stem Cell Transplant in Patients With Hematological Malignancies

    Not yet reported National Cancer Institute (NCI) 12 participants Est. completion 2014-03 1 site Stand-alone
    Obstructive sleep apnea Other conditions: Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Adult Grade III Lymphomatoid Granulomatosis, B-cell Chronic Lymphocytic Leukemia, Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Chronic Myelomonocytic Leukemia, Chronic Phase Chronic Myelogenous Leukemia, Contiguous Stage II Adult Burkitt Lymphoma, Contiguous Stage II Adult Diffuse Large Cell Lymphoma, Contiguous Stage II Adult Diffuse Mixed Cell Lymphoma, Contiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma, Contiguous Stage II Adult Immunoblastic Large Cell Lymphoma, Contiguous Stage II Adult Lymphoblastic Lymphoma, Contiguous Stage II Grade 1 Follicular Lymphoma, Contiguous Stage II Grade 2 Follicular Lymphoma, Contiguous Stage II Grade 3 Follicular Lymphoma, Contiguous Stage II Mantle Cell Lymphoma, Contiguous Stage II Marginal Zone Lymphoma, Contiguous Stage II Small Lymphocytic Lymphoma, Cutaneous B-cell Non-Hodgkin Lymphoma, Graft Versus Host Disease, Intraocular Lymphoma, Myelodysplastic Syndrome With Isolated Del(5q), Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable, Nodal Marginal Zone B-cell Lymphoma, Noncontiguous Stage II Adult Burkitt Lymphoma, Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma, Noncontiguous Stage II Adult Diffuse Mixed Cell Lymphoma, Noncontiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma, Noncontiguous Stage II Adult Immunoblastic Large Cell Lymphoma, Noncontiguous Stage II Adult Lymphoblastic Lymphoma, Noncontiguous Stage II Grade 1 Follicular Lymphoma, Noncontiguous Stage II Grade 2 Follicular Lymphoma, Noncontiguous Stage II Grade 3 Follicular Lymphoma, Noncontiguous Stage II Mantle Cell Lymphoma, Noncontiguous Stage II Marginal Zone Lymphoma, Noncontiguous Stage II Small Lymphocytic Lymphoma, Post-transplant Lymphoproliferative Disorder, Primary Central Nervous System Hodgkin Lymphoma, Primary Central Nervous System Non-Hodgkin Lymphoma, Recurrent Adult Acute Myeloid Leukemia, Recurrent Adult Burkitt Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma, Recurrent Adult Diffuse Mixed Cell Lymphoma, Recurrent Adult Diffuse Small Cleaved Cell Lymphoma, Recurrent Adult Grade III Lymphomatoid Granulomatosis, Recurrent Adult Hodgkin Lymphoma, Recurrent Adult Immunoblastic Large Cell Lymphoma, Recurrent Adult Lymphoblastic Lymphoma, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Grade 3 Follicular Lymphoma, Recurrent Mantle Cell Lymphoma, Recurrent Marginal Zone Lymphoma, Recurrent Small Lymphocytic Lymphoma, Refractory Anemia, Refractory Anemia With Excess Blasts, Refractory Anemia With Ringed Sideroblasts, Refractory Chronic Lymphocytic Leukemia, Refractory Cytopenia With Multilineage Dysplasia, Refractory Hairy Cell Leukemia, Relapsing Chronic Myelogenous Leukemia, Secondary Central Nervous System Hodgkin Lymphoma, Secondary Central Nervous System Non-Hodgkin Lymphoma, Small Intestine Lymphoma, Splenic Marginal Zone Lymphoma, Stage I Adult Burkitt Lymphoma, Stage I Adult Diffuse Large Cell Lymphoma, Stage I Adult Diffuse Mixed Cell Lymphoma, Stage I Adult Diffuse Small Cleaved Cell Lymphoma, Stage I Adult Hodgkin Lymphoma, Stage I Adult Immunoblastic Large Cell Lymphoma, Stage I Adult Lymphoblastic Lymphoma, Stage I Chronic Lymphocytic Leukemia, Stage I Grade 1 Follicular Lymphoma, Stage I Grade 2 Follicular Lymphoma, Stage I Grade 3 Follicular Lymphoma, Stage I Mantle Cell Lymphoma, Stage I Marginal Zone Lymphoma, Stage I Small Lymphocytic Lymphoma, Stage II Adult Hodgkin Lymphoma, Stage II Chronic Lymphocytic Leukemia, Stage III Adult Burkitt Lymphoma, Stage III Adult Diffuse Large Cell Lymphoma, Stage III Adult Diffuse Mixed Cell Lymphoma, Stage III Adult Diffuse Small Cleaved Cell Lymphoma, Stage III Adult Hodgkin Lymphoma, Stage III Adult Immunoblastic Large Cell Lymphoma, Stage III Adult Lymphoblastic Lymphoma, Stage III Chronic Lymphocytic Leukemia, Stage III Grade 1 Follicular Lymphoma, Stage III Grade 2 Follicular Lymphoma, Stage III Grade 3 Follicular Lymphoma, Stage III Mantle Cell Lymphoma, Stage III Marginal Zone Lymphoma, Stage IV Adult Burkitt Lymphoma, Stage IV Adult Diffuse Large Cell Lymphoma, Stage IV Adult Diffuse Mixed Cell Lymphoma, Stage IV Adult Diffuse Small Cleaved Cell Lymphoma, Stage IV Adult Hodgkin Lymphoma, Stage IV Adult Immunoblastic Large Cell Lymphoma, Stage IV Adult Lymphoblastic Lymphoma, Stage IV Chronic Lymphocytic Leukemia, Stage IV Grade 1 Follicular Lymphoma, Stage IV Grade 2 Follicular Lymphoma, Stage IV Grade 3 Follicular Lymphoma, Stage IV Mantle Cell Lymphoma, Stage IV Marginal Zone Lymphoma, Stage IV Small Lymphocytic Lymphoma, Testicular Lymphoma, Waldenström Macroglobulinemia
    View official trial listing →
  • Completed NCT NCT01789619

    Extended Release Tacrolimus (Advagraf®) in Severe Adult Atopic Dermatitis Patients

    UMC Utrecht 9 participants Est. completion 2014-01 1 site
    Other conditions: Atopic Dermatitis
    View official trial listing →
  • Terminated NCT NCT01797315

    Prevention of Skin Cancer in High Risk Patients After Conversion to a Sirolimus-based Immunosuppressive Protocol

    Not yet reported University Hospital of Berlin 40 participants Est. completion 2013-06
    Other conditions: Renal Transplant Patients at High-risk for Skin Cancer
    View official trial listing →
  • Completed NCT NCT01797341

    Prograf-Advagraf Cross Over Conversion Study

    Not yet reported University Health Network, Toronto 13 participants Est. completion 2014-02 1 site Stand-alone
    Other conditions: Kidney-Pancreas Transplantation
    View official trial listing →
  • Completed NCT NCT01810588

    Targeting the IPA and Matching for the Non-Inherited Maternal Antigen for Haplo-Cord Transplantation

    Not yet reported Weill Medical College of Cornell University 270 participants Est. completion 2026-03-24 2 sites Stand-alone
    Other conditions: Hematologic Malignancies
    View official trial listing →
  • Completed NCT NCT01824693

    Busulfan, Cyclophosphamide, and Melphalan or Busulfan and Fludarabine Phosphate Before Donor Hematopoietic Cell Transplant in Treating Younger Patients With Juvenile Myelomonocytic Leukemia

    Not yet reported Children's Oncology Group 30 participants Est. completion 2017-12-31 50 sites Stand-alone
    Other conditions: Juvenile Myelomonocytic Leukemia
    View official trial listing →
  • Completed NCT NCT01843348

    12 Month Athena Study: Everolimus vs. Standard Regimen in de Novo Kidney Transplant Patients

    Not yet reported Novartis Pharmaceuticals 612 participants Est. completion 2016-03-23 27 sites Stand-alone
    Other conditions: Kidney Transplantation, Renal Transplantation
    View official trial listing →
  • Completed NCT NCT01850979

    Treatment of Dry Eye Using 0.03% Tacrolimus Eye Drops

    Not yet reported University of Sao Paulo General Hospital 24 participants Est. completion 2011-11 1 site
    Other conditions: Sjogren Syndrome, Dry Eye Syndrome
    View official trial listing →
  • Completed NCT NCT01858740

    Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts in Preventing GVHD in Children

    Not yet reported Fred Hutchinson Cancer Center 20 participants Est. completion 2023-07-30 1 site Stand-alone
    Other conditions: Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Biphenotypic Leukemia, Acute Leukemia of Ambiguous Lineage, Acute Undifferentiated Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Childhood Acute Lymphoblastic Leukemia in Remission, Childhood Acute Myeloid Leukemia in Remission, Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Myelodysplastic Syndrome With Excess Blasts-1, Myelodysplastic Syndrome With Excess Blasts-2, Recurrent Adult Acute Lymphoblastic Leukemia, Recurrent Adult Acute Myeloid Leukemia, Recurrent Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood Acute Myeloid Leukemia, Refractory Adult Acute Lymphoblastic Leukemia, Refractory Childhood Acute Lymphoblastic Leukemia
    View official trial listing →
  • Completed NCT NCT01870908

    Special Drug Use-Results Survey of Prograf Capsule in Rheumatoid Arthritis Patients

    Astellas Pharma Inc 664 participants Est. completion 2015-03 7 sites
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Terminated NCT NCT01875237

    Donor Lymphocyte Infusion (DLI) of T-cells Genetically Modified With iCasp9 Suicide Gene

    Not yet reported, Not yet reported M.D. Anderson Cancer Center 3 participants Est. completion 2017-03-07 1 site Stand-alone
    Other conditions: Leukemia, Myeloma, Myeloproliferative Diseases
    View official trial listing →
  • Terminated NCT NCT01878786

    A Pilot Study Comparing the Safety and Efficacy of Everolimus With Other Medicines in Recipients of ECD/DCD Kidneys

    Not yet reported, Not yet reported Matthew Cooper 25 participants Est. completion 2017-12 1 site Stand-alone
    Other conditions: Delayed Graft Function
    View official trial listing →
  • Completed NCT NCT01882322

    A Study to Evaluate the Effect of Advagraf Conversion From Prograf in Liver Transplant Subjects

    Not yet reported Astellas Pharma Korea, Inc. 36 participants Est. completion 2017-01-03 1 site Stand-alone
    Other conditions: de Novo Liver Transplant Subjects
    View official trial listing →
  • Completed NCT NCT01884480

    Renal Function and Pharmacogenetics in Renal Transplant Recipients Converted From Tac BID to Tac OD

    Unity Health Toronto 60 participants Est. completion 2014-09 1 site
    Other conditions: Real Function Post Conversion From Prograf to Advagraf, Examin Ethnicity and Pharmacogenetics of the Cohort Requiring Dose Adjustment Post-conversion
    View official trial listing →
  • Completed NCT NCT01887171

    Evaluation of Preimplantation Portal Vein and Hepatic Artery Flushing With Tacrolimus

    Not yet reported Republican Scientific and Practical Center for Organ and Tissue Transplantation 86 participants Est. completion 2014-07 1 site Stand-alone
    Other conditions: Early Allograft Dysfunction, Ischemic Reperfusion Injury, Liver Transplantation, Hyperfibrinolysis
    View official trial listing →
  • Completed NCT NCT01888432

    Efficacy and Safety of Everolimus in Liver Transplant Recipients of Living Donor Liver Transplants

    Not yet reported Novartis Pharmaceuticals 285 participants Est. completion 2018-04-21 42 sites Stand-alone
    Other conditions: Liver Transplantation
    View official trial listing →
  • Completed NCT NCT01895049

    Comparison Between Two Tacrolimus-based Immunosuppressant Regimens and Induction With Thymoglobulin in Kidney Transplants From Deceased Donors With Expanded Criteria

    Not yet reported Helio Tedesco Silva Junior 171 participants Est. completion 2017-03-07 1 site Stand-alone
    Other conditions: Kidney Transplantation, Cytomegalovirus
    View official trial listing →
  • Status unknown NCT NCT01927588

    Evaluation of Early Use of Everolimus (EVE) on Cytomegalovirus (CMV) Infection in Renal Transplant Recipients

    Not yet reported Fundação Pró Rim 50 participants Est. completion 2015-11 Stand-alone
    Other conditions: Cytomegalovirus Infections
    View official trial listing →
  • Completed NCT NCT01936519

    Conversion to Everolimus From Calcineurin Inhibitor With Mycophenolic Acid: Impact on Long Term Renal Function in Liver Transplantation.

    Not yet reported Milton S. Hershey Medical Center 24 participants Est. completion 2019-07-31 1 site
    Other conditions: Immunosuppression, Renal Failure
    View official trial listing →
  • Completed NCT NCT01955187

    Sequential Therapy With Tacrolimus and Rituximab in Primary Membranous Nephropathy

    Not yet reported Hospital Universitario 12 de Octubre 86 participants Est. completion 2019-06-26 1 site Stand-alone
    Other conditions: MEMBRANOUS NEPHROPATHY
    View official trial listing →
  • Completed NCT NCT01958190

    Study Comparing in Livertransplantation Recipients With Tacrolimus Alone Versus Tacrolimus&Sirolimus

    Not yet reported Foundation for Liver Research 196 participants Est. completion 2021-05-20 3 sites Stand-alone
    Other conditions: Liver Disease
    View official trial listing →
  • Completed NCT NCT01982682

    Allogeneic Hematopoietic Stem Cell Transplantation for High-Risk Hematologic Malignancies Using One Haploidentical Donor

    Not yet reported Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 41 participants Est. completion 2017-03-27 1 site Stand-alone
    Other conditions: Hematopoietic/Lymphoid Cancer
    View official trial listing →
  • Status unknown NCT NCT01983761

    Study of ASC-101 in Patients With Hematologic Malignancies Who Receive Dual-cord Umbilical Cord Blood Transplantation

    Not yet reported, Not yet reported Targazyme, Inc. 25 participants 4 sites
    Other conditions: Blood And Marrow Transplantation, Leukemia, Lymphoma, Transplantation Infection, Myelodysplastic Syndrome (MDS), Non-Hodgkin's Lymphoma (NHL), Hodgkin's Lymphoma
    View official trial listing →
  • Completed NCT NCT02016625

    Investigation of Potential Drug-drug Interactions Between Faldaprevir and the Immunosuppressant Drugs Cyclosporine or Tacrolimus

    Not yet reported Boehringer Ingelheim 32 participants Est. completion 2014-04 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Status unknown NCT NCT02036554

    Evaluate Efficacy Study of Combination Therapy of Everolimus and Low Dose Tacrolimus in Renal Allograft Recipients

    Not yet reported Seoul St. Mary's Hospital 234 participants Est. completion 2015-12 1 site Stand-alone
    Other conditions: Kidney; Complications, Allograft
    View official trial listing →
  • Completed NCT NCT02077556

    Effect of Everolimus on the Pharmacokinetics of Tacrolimus in Renal Transplant Patients

    Not yet reported National Taiwan University Hospital 14 participants Est. completion 2019-01-15 1 site Stand-alone
    Other conditions: Drug Interaction Potentiation
    View official trial listing →
  • Enrolling by invitation NCT NCT02081755

    Safety and Efficacy of Everolimus Treatment in Liver Transplantation for Liver Cancer

    Not yet reported Baylor Research Institute 336 participants Est. completion 2027-03 9 sites Stand-alone
    Other conditions: Carcinoma, Hepatocellular
    View official trial listing →
  • Completed NCT NCT02083991

    Trial of Steroid Avoidance and Low-dose CNI by ATG-induction in Renal Transplantation

    Not yet reported Vastra Gotaland Region 224 participants Est. completion 2017-12 1 site
    Other conditions: Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT02084446

    Everolimus + Very Low Tacrolimus vs Enteric-coated Mycophenolate Sodium + Low Tacrolimus in de Novo Renal Transplant

    Not yet reported Ronaldo de Matos Esmeraldo, MD 120 participants Est. completion 2017-07 1 site Stand-alone
    Other conditions: Transplantation Infection, Cytomegalovirus Infections
    View official trial listing →
  • Status unknown NCT NCT02108301

    Hepatitis C in Renal Transplant Recipients

    Not yet reported Prof. Dr. Alice Schmidt 30 participants 1 site Stand-alone
    Other conditions: Chronic Hepatitis C-virus Infection, Renal Transplantation
    View official trial listing →
  • Withdrawn NCT NCT02113891

    Eculizumab Therapy for Subclinical Antibody-mediated Rejection in Kidney Transplantation

    Not yet reported, Not yet reported Assistance Publique - Hôpitaux de Paris Est. completion 2017-11 Stand-alone
    Other conditions: Subclinical Acute Antibody-mediated Rejection in Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT02120157

    Myeloablative Haploidentical BMT With Post-transplant Cyclophosphamide for Pediatric Patients With Hematologic Malignancies

    Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 35 participants Est. completion 2020-10-01 9 sites Stand-alone
    Other conditions: Myeloablative Conditioning, HLA-mismatched Bone Marrow Transplantation, Graft Survival, Transplantation, Bone Marrow
    View official trial listing →
  • Completed NCT NCT02122081

    Organ-Sparing Marrow-Targeted Irradiation Before Stem Cell Transplant in Treating Patients With High-Risk Hematologic Malignancies

    Not yet reported Sumithira Vasu 33 participants Est. completion 2022-09-06 1 site Stand-alone
    Other conditions: Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), de Novo Myelodysplastic Syndromes, Previously Treated Myelodysplastic Syndromes, Recurrent Adult Acute Lymphoblastic Leukemia, Recurrent Adult Acute Myeloid Leukemia, Secondary Myelodysplastic Syndromes, Untreated Adult Acute Lymphoblastic Leukemia, Untreated Adult Acute Myeloid Leukemia
    View official trial listing →
  • Completed NCT NCT02123108

    Safety and Efficacy of Basiliximab, Delayed Dose Tacrolimus Plus ECMPA (Enteric Coated Mycophenolic Acid) Following Liver Transplantation

    Not yet reported University of California, Los Angeles 59 participants Est. completion 2015-01 1 site Stand-alone
    Other conditions: Liver Transplantation
    View official trial listing →
  • Completed NCT NCT02129582

    Targeted Marrow Irradiation, Fludarabine Phosphate, and Busulfan Before Donor Progenitor Cell Transplant in Treating Patients With Hematologic Malignancies

    Not yet reported Case Comprehensive Cancer Center 14 participants Est. completion 2020-03-05 1 site Stand-alone
    Other conditions: Acute Myeloid Leukemia, Hematologic Malignancies, Acute Lymphocytic Leukemia, Non Hodgkin Lymphoma, Hodgkin Lymphoma, Multiple Myeloma, Myelodysplastic Syndrome, Chronic Lymphocytic Leukemia, Chronic Myeloid Leukemia, Myelofibrosis, Myeloproliferative Syndrome
    View official trial listing →
  • Completed NCT NCT02129881

    The ONE Study UK Treg Trial

    Not yet reported, Not yet reported Guy's and St Thomas' NHS Foundation Trust 15 participants Est. completion 2017-03-23 2 sites Stand-alone
    Other conditions: End-stage Renal Failure
    View official trial listing →
  • Completed NCT NCT02147938

    A Study of Renal Transplant Patients Converted From the Twice Per Day Form of Tacrolimus (Prograf®) to the Once Per Day Form (Advagraf®)

    Astellas Pharma S.A.S. 578 participants Est. completion 2017-05-15 26 sites
    Other conditions: Renal Transplantation
    View official trial listing →
  • Completed NCT NCT02159651

    A Survey for Long-term Use of Prograf Capsules in Patient With Interstitial Pneumonia

    Astellas Pharma Inc 179 participants Est. completion 2019-12-23 8 sites
    Other conditions: Interstitial Pneumonia Associated With Polymyositis/Dermatomyositis
    View official trial listing →
  • Completed NCT NCT02160054

    Specified Drug Use-results Survey of Graceptor in Patients With Kidney Transplantation (Switching From Cyclosporine)

    Astellas Pharma Inc 289 participants Est. completion 2016-03-31 30 sites
    Other conditions: the Maintenance Phase After Kidney Transplantation
    View official trial listing →
  • Status unknown NCT NCT02208791

    Effects of the Quadruple Immunosuppression on Peripheral Blood Lymphocytes and Development of Anti-HLA Antibodies in Kidney Transplant

    Not yet reported University of Sao Paulo General Hospital 45 participants Est. completion 2017-07 1 site Stand-alone
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT02224872

    Transplantation of Partially Mismatched Related or Matched Unrelated Bone Marrow for Patients With Refractory Severe Aplastic Anemia

    Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 18 participants Est. completion 2021-12 2 sites Stand-alone
    Other conditions: Severe Aplastic Anemia, Bone Marrow Failure Syndromes
    View official trial listing →
  • Completed NCT NCT02248597

    Donor Stem Cell Transplant Followed by Cyclophosphamide in Treating Patients With Hematological Diseases

    Not yet reported Wake Forest University Health Sciences 27 participants Est. completion 2023-01-18 1 site Stand-alone
    Other conditions: Graft Versus Host Disease, Hematopoietic/Lymphoid Cancer
    View official trial listing →
  • Completed NCT NCT02266888

    B Cell Induction in Pediatric Lung Transplantation

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 45 participants Est. completion 2019-06-30 7 sites Stand-alone
    Other conditions: Lung Transplant
    View official trial listing →
  • Terminated NCT NCT02268201

    A Study to Evaluate the Efficacy and Safety in Kidney Transplant Recipients When Changed From Cyclosporine to Tacrolimus Prolonged-release Capsule or Tacrolimus Capsule

    Not yet reported Astellas Pharma China, Inc. 17 participants Est. completion 2015-03-31 7 sites Stand-alone
    Other conditions: Kidney Transplant Recipients
    View official trial listing →
  • Status unknown NCT NCT02291770

    Treatment of Chronic Graft-Versus-Host Disease With Mesenchymal Stromal Cells

    Not yet reported Guangdong Provincial People's Hospital 130 participants Est. completion 2019-12 1 site
    Other conditions: Chronic Graft-Versus-Host Disease
    View official trial listing →
  • Completed NCT NCT02294032

    The Role of B Cells in Kidney Allograft Dysfunction

    Loma Linda University 180 participants Est. completion 2023-04-24 1 site
    Other conditions: Kidney; Complications, Allograft, Transplantation Infection
    View official trial listing →
  • Completed NCT NCT02297126

    A Prospective Trial to Assess Cost and Clinical Outcomes of a Clinical Pharmacogenomic Program

    Not yet reported Indiana University 4465 participants Est. completion 2019-05-03 1 site
    Other conditions: Adverse Drug Reaction
    View official trial listing →
  • Status unknown NCT NCT02300571

    Observational Study of the Combination of Post-transplant High Dose Cyclophosphamide, Tacrolimus and Mycophenolate Mofetil for the Prevention of Acute Graft-versus-Host Disease in Patients Eligible to Allogeneic Hematopoietic Stem Cell Transplant

    Fondazione del Piemonte per l'Oncologia 60 participants Est. completion 2018-01 2 sites
    Other conditions: Hematological Malignancies
    View official trial listing →
  • Completed NCT NCT02328755

    Peginterferon Alfa-2a to Enhance Anti-leukemic Responses After Allogeneic Transplantation in Acute Myeloid Leukemia

    Not yet reported, Not yet reported University of Michigan Rogel Cancer Center 37 participants Est. completion 2019-03-25 1 site Stand-alone
    Other conditions: Acute Myeloid Leukemia
    View official trial listing →
  • Completed NCT NCT02336854

    Tacrobell tab_Phase1_PK

    Not yet reported Chong Kun Dang Pharmaceutical 50 participants Est. completion 2015-03-19
    Other conditions: Immunosuppressant(Organ Transplantation, RA)
    View official trial listing →
  • Completed NCT NCT02342145

    Efficacy of Basiliximab in the Prevention of Acute Graft-versus-host Disease in Unrelated Allogeneic Hematopoietic Stem Cell Transplantation Therapy for Thalassemia Major

    Not yet reported Zhongming Zhang 205 participants Est. completion 2022-08-20 3 sites Stand-alone
    Other conditions: Beta-Thalassemia Major, Graft-versus-host Disease (GVHD)
    View official trial listing →
  • Completed NCT NCT02356159

    Study of Palifermin (Kepivance) in Persons Undergoing Unrelated Donor Allogeneic Hematopoietic Cell Transplantation

    Not yet reported, Not yet reported National Cancer Institute (NCI) 34 participants Est. completion 2025-03-25 2 sites Stand-alone
    Other conditions: Myelodysplastic Syndromes, Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma, Acute Leukemia, Multiple Myeloma
    View official trial listing →
  • Completed NCT NCT02373202

    A Study Assessing the Safety and Efficacy of Sarilumab Added to Non-MTX DMARDs or as Monotherapy in Japanese Patients With Active Rheumatoid Arthritis (SARIL-RA-HARUKA)

    Not yet reported Sanofi 91 participants Est. completion 2016-11 40 sites Stand-alone
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Status unknown NCT NCT02392780

    Cannabidiol for the Treatment of Severe (Grades III/IV) Acute Graft-versus-host Disease

    Not yet reported moshe yeshurun 10 participants 1 site Stand-alone
    Other conditions: Acute-graft-versus-host Disease
    View official trial listing →
  • Withdrawn NCT NCT02409147

    Initiation of a Deceased Donor Uterine Transplantation Program at the University of Nebraska Medical Center

    Not yet reported University of Nebraska Est. completion 2018-07-24 Stand-alone
    Other conditions: Uterus Transplant
    View official trial listing →
  • Status unknown NCT NCT02416674

    Vascularized Composite Allotransplantation for Treatment of Abdominal Wall Defects

    Not yet reported Brigham and Women's Hospital 10 participants Est. completion 2025-02 1 site Stand-alone
    Other conditions: Abdominal Wall Defect
    View official trial listing →
  • Withdrawn NCT NCT02447055

    Allogeneic Stem Cell Transplantation for Patients With Multiple Myeloma

    Not yet reported Washington University School of Medicine Est. completion 2016-06 Stand-alone
    Other conditions: Multiple Myeloma, Myeloma-Multiple
    View official trial listing →
  • Status unknown NCT NCT02453867

    Efficacy and Safety of a Reduced Immunosuppression vs. Standard Triple Therapy in Senior Renal Transplant Recipients

    Not yet reported Klemens Budde 400 participants Est. completion 2019-07 Stand-alone
    Other conditions: Immunosuppression After Renal Transplantation
    View official trial listing →
  • Status unknown NCT NCT02459977

    The Usefulness of Tacrolimus Without Basiliximab in Well Matched Living Renal Transplantation in Korea

    Not yet reported Asan Medical Center 40 participants 1 site
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Status unknown NCT NCT02496494

    The Effects of Conversion From Cyclosporine to Tacrolimus on the Changes of Cardiovascular Risk Profiles and Serum Metabolites in Renal Transplant Recipients

    Not yet reported Kyungpook National University Hospital 50 participants Est. completion 2015-12 1 site Stand-alone
    Other conditions: CYCLOSPORINE/TACROLIMUS
    View official trial listing →
  • Withdrawn NCT NCT02528877

    Ruxolitinib Phosphate, Tacrolimus and Sirolimus in Preventing Acute Graft-versus-Host Disease During Reduced Intensity Donor Hematopoietic Cell Transplant in Patients With Myelofibrosis

    Not yet reported City of Hope Medical Center 1 site Stand-alone
    Other conditions: Acute Myeloid Leukemia in Remission, Primary Myelofibrosis, Primary Myelofibrosis, Prefibrotic Stage, Secondary Acute Myeloid Leukemia, Secondary Myelofibrosis
    View official trial listing →
  • Completed NCT NCT02540395

    Prospective Donor Specific T Response Measurment for IS Minimization in de Novo Renal Transplantation

    Not yet reported Prof. Dr. Petra Reinke 184 participants Est. completion 2020-10-31 8 sites Stand-alone
    Other conditions: Disorder Related to Renal Transplantation, Effects of Immunosuppressant Therapy
    View official trial listing →
  • Completed NCT NCT02555787

    Global, Multicentre, Non Interventional Advagraf Conversion Registry in Kidney Transplant Patients

    Astellas Pharma Europe Ltd. 4430 participants Est. completion 2022-09-30 129 sites
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Not yet recruiting NCT NCT02558452

    European Transplant Registry of Senior Renal Transplant Recipients on Advagraf

    Klemens Budde 1000 participants Est. completion 2028-01
    Other conditions: Graft Failure, Death, Acute Rejection of Renal Transplant, Infections, Bone Disease, Post Transplant Diabetes Mellitus, Quality of Life, HLA Antibody Production, Cardiovascular Risk Factors, Non-HLA Antibody Production
    View official trial listing →
  • Withdrawn NCT NCT02563782

    Study to Evaluate Sub-retinal Transplantation of Retinal Pigmented Epithelial Cells in Patients With Dry AMD

    Not yet reported Astellas Institute for Regenerative Medicine Est. completion 2017-05-05 1 site
    Other conditions: Age-Related Macular Degeneration
    View official trial listing →
  • Completed NCT NCT02582775

    MT2015-20: Biochemical Correction of Severe EB by Allo HSCT and Serial Donor MSCs

    Not yet reported Masonic Cancer Center, University of Minnesota 17 participants Est. completion 2023-07-26 1 site Stand-alone
    Obstructive sleep apnea
    View official trial listing →
  • Status unknown NCT NCT02602873

    Study of Tacrolimus Used for Pediatric Patients With Nephrotic Syndrome Based on Pharmacogenomics and Metabonomics

    Guangzhou Women and Children's Medical Center 150 participants Est. completion 2020-08 1 site
    Other conditions: Nephrotic Syndrome
    View official trial listing →
  • Terminated NCT NCT02627573

    Trial of GVHD Prophylasxis With PTCy or Thymoglobulin in Unrelated SCT

    Not yet reported St. Petersburg State Pavlov Medical University 32 participants Est. completion 2019-04-03 1 site Stand-alone
    Other conditions: Leukemia, Chronic Myeloid, Myelodysplastic Syndromes, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
    View official trial listing →
  • Completed NCT NCT02644395

    Thiazide Diuretics for Hypertension in Kidney Transplant Recipients Using Tacrolimus

    Not yet reported Erasmus Medical Center 49 participants Est. completion 2016-12-19 1 site
    Other conditions: Hypertension, Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT02652468

    TCR-α/β and CD19 Depleted Stem Cell Grafts From Haplo Donors for HSCT in Relapsed Lymphoma

    Not yet reported University of Wisconsin, Madison 11 participants Est. completion 2021-09-17 1 site Stand-alone
    Other conditions: Lymphoma
    View official trial listing →
  • Status unknown NCT NCT02707822

    The Influence of ABCB1、CYP3A4、CYP3A5、POR Genetic Polymorphism and Other Factors on Tacrolimus Blood Concentration

    National Taiwan University Hospital 440 participants Est. completion 2018-12 1 site
    Other conditions: Kidney Transplantation, Liver Transplantation
    View official trial listing →
  • Completed NCT NCT02711826

    Treg Therapy in Subclinical Inflammation in Kidney Transplantation

    Not yet reported, Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 32 participants Est. completion 2023-08-04 6 sites Stand-alone
    Other conditions: Kidney Transplant, Adult Living Donor Kidney Transplant Recipients, Renal Transplant, Living Kidney Donor
    View official trial listing →
  • Terminated NCT NCT02723786

    Efficacy, Safety, Tolerability and Pharmacokinetic (PK) Study of GSK1070806 for the Prevention of Delayed Graft Function (DGF) in Adult Subjects After Renal Transplantation

    Not yet reported GlaxoSmithKline 7 participants Est. completion 2018-03-06 4 sites Stand-alone
    Other conditions: Kidney Transplantation (Status Post)
    View official trial listing →
  • Completed NCT NCT02736227

    Biomarkers Predicting Successful Tacrolimus Withdrawal and Everolimus (Zortress) Monotherapy Early After Liver Transplantation

    Not yet reported Northwestern University 28 participants Est. completion 2021-03 1 site Stand-alone
    Other conditions: Liver Transplantation
    View official trial listing →
  • Completed NCT NCT02741323

    Impact of CCR5 Blockade in HIV+ Kidney Transplant Recipients

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 97 participants Est. completion 2022-05-10 10 sites Stand-alone
    Other conditions: HIV Infections, Kidney Diseases
    View official trial listing →
  • Status unknown NCT NCT02759822

    Haploidentical Hematopoietic Stem Cell Transplantation for Acute Leukemias

    Leonardo Javier Arcuri 30 participants 1 site
    Other conditions: Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma
    View official trial listing →
  • Completed NCT NCT02766465

    Bone Marrow Transplantation vs Standard of Care in Patients With Severe Sickle Cell Disease (BMT CTN 1503)

    Not yet reported Medical College of Wisconsin 138 participants Est. completion 2023-08-02 35 sites Stand-alone
    Other conditions: Sickle Cell Disease
    View official trial listing →
  • Active, not recruiting NCT NCT02782546

    Cytokine Induced Memory-like NK Cell Adoptive Therapy After Haploidentical Donor Hematopoietic Cell Transplantation

    Not yet reported Washington University School of Medicine 60 participants Est. completion 2028-02-13 1 site Stand-alone
    Other conditions: Acute Myeloid Leukemia
    View official trial listing →
  • Active, not recruiting NCT NCT02790515

    Provision of TCRγδ T Cells and Memory T Cells Plus Selected Use of Blinatumomab in Naïve T-cell Depleted Haploidentical Donor Hematopoietic Cell Transplantation for Hematologic Malignancies Relapsed or Refractory Despite Prior Transplantation

    Not yet reported St. Jude Children's Research Hospital 170 participants Est. completion 2026-07-01 1 site Stand-alone
    Other conditions: Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML), Myeloid Sarcoma, Chronic Myeloid Leukemia (CML), Juvenile Myelomonocytic Leukemia (JMML), Myelodysplastic Syndrome (MDS), Non-Hodgkin Lymphoma (NHL)
    View official trial listing →
  • Status unknown NCT NCT02794610

    Ocular Penetration of Topical Tacrolimus Eye Drops

    Not yet reported The Eye Center and The Eye Foundation for Research in Ophthalmology 10 participants Est. completion 2016-07 1 site Stand-alone
    Other conditions: Ocular Penetration of Topical Tacrolimus
    View official trial listing →
  • Completed NCT NCT02820259

    Therapeutic Drug Monitoring of Tacrolimus Biliary Concentrations for Liver-transplanted Patients (STABILE)

    Rennes University Hospital 42 participants Est. completion 2017-04-07 1 site
    Other conditions: Biliary Concentration of Tacrolimus
    View official trial listing →
  • Completed NCT NCT02833805

    NMA Haplo or MUD BMT for Newly Diagnosed Severe Aplastic Anemia

    Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 21 participants Est. completion 2021-07 1 site Stand-alone
    Other conditions: Severe Aplastic Anemia, Aplastic Anemia, Bone Marrow Failure, Immunosuppression
    View official trial listing →
  • Active, not recruiting NCT NCT02861417

    Busulfan, Fludarabine Phosphate, and Post-Transplant Cyclophosphamide in Treating Patients With Blood Cancer Undergoing Donor Stem Cell Transplant

    Not yet reported M.D. Anderson Cancer Center 204 participants Est. completion 2028-08-31 1 site Stand-alone
    Other conditions: Hematopoietic and Lymphoid Cell Neoplasm, High Risk Acute Myeloid Leukemia, High Risk Myelodysplastic Syndrome, Lymphoproliferative Disorder, Myelodysplastic Syndrome, Myelodysplastic/Myeloproliferative Neoplasm, Recurrent Acute Lymphoblastic Leukemia, Recurrent Acute Myeloid Leukemia, Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Recurrent High Risk Myelodysplastic Syndrome, Recurrent Hodgkin Lymphoma, Recurrent Myelodysplastic Syndrome, Recurrent Non-Hodgkin Lymphoma, Recurrent Plasma Cell Myeloma
    View official trial listing →
  • Completed NCT NCT02877628

    Immunosuppressive Therapy Optimization: Development of a Population Pharmacokinetic-pharmacodynamic (PK-PD) Model in Liver Transplantation

    Rennes University Hospital 110 participants Est. completion 2018-12 1 site
    Other conditions: Liver Transplantation
    View official trial listing →
  • Status unknown NCT NCT02882113

    Influence of CYP3A5 Polymorphism on Liver Function Abnormality and the Trough Level Change After Conversion

    Not yet reported Seoul National University Hospital 60 participants Est. completion 2018-12 1 site Stand-alone
    Other conditions: Liver Dysfunction
    View official trial listing →
  • Completed NCT NCT02885610

    Study of RC18 Administered Subcutaneously to Subjects With Systemic Lupus Erythematosus(SLE)

    Not yet reported RemeGen Co., Ltd. 249 participants Est. completion 2019-07-09 1 site Stand-alone
    Other conditions: Systemic Lupus Erythematosus
    View official trial listing →
  • Completed NCT NCT02891603

    A Phase I/II GVHD Prevention Trial Combining Pacritinib With Sirolimus-Based Immune Suppression

    Not yet reported, Not yet reported H. Lee Moffitt Cancer Center and Research Institute 40 participants Est. completion 2022-04-18 2 sites Stand-alone
    Other conditions: Graft Vs Host Disease, GVHD
    View official trial listing →
  • Terminated NCT NCT02954159

    Vedolizumab Monotherapy Vs Combination Therapy With Tacrolimus in UC

    Not yet reported Medical College of Wisconsin 4 participants Est. completion 2019-01-31 1 site
    Other conditions: Ulcerative Colitis
    View official trial listing →
  • Status unknown NCT NCT02957552

    Safety and Tolerance of Immunomodulating Therapy With Donor-specific MSC in Pediatric Living-Donor Liver Transplantation

    Not yet reported University Hospital Tuebingen 7 participants Est. completion 2021-12 1 site Stand-alone
    Other conditions: Pediatric Liver Transplantation
    View official trial listing →
  • Completed NCT NCT02970630

    Envarsus® Once Daily With Everolimus in Elderly Kidney Transplant Recipients: Pharmacokinetic and Clinical Study

    Not yet reported Chiesi Farmaceutici S.p.A. 28 participants Est. completion 2018-02-22 6 sites Stand-alone
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT03020589

    Study of Pharmacogenomic-Guided Tacrolimus Dosing and Monitoring in Kidney Transplant Recipients

    Not yet reported University of North Carolina, Chapel Hill 97 participants Est. completion 2022-06-28 1 site Stand-alone
    Other conditions: Renal Transplant
    View official trial listing →
  • Suspended NCT NCT03042637

    Safety and Efficacy of Combination Acthar Gel and Tacrolimus in the Treatment of Steroid Resistant Nephrotic Syndrome

    Southeast Renal Research Institute Est. completion 2021-12 1 site
    Other conditions: Nephrotic Syndrome
    View official trial listing →
  • Active, not recruiting NCT NCT03114865

    A Study of Blinatumomab in Patients With Pre B-cell ALL and B-cell NHL as Post-allo-HSCT Remission Maintenance

    Not yet reported, Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 44 participants Est. completion 2026-10-30 1 site
    Other conditions: Acute Lymphoblastic Leukemia, B-cell Non Hodgkin Lymphoma, Pre B-Cell Acute Lymphoblastic Leukaemia
    View official trial listing →
  • Active, not recruiting NCT NCT03118492

    Combination Chemotherapy, Total Body Irradiation, and Donor Blood Stem Cell Transplant in Treating Patients With Secondary Myelofibrosis

    Not yet reported City of Hope Medical Center 22 participants Est. completion 2027-04-29 1 site Stand-alone
    Other conditions: Secondary Myelofibrosis
    View official trial listing →
  • Status unknown NCT NCT03147157

    The Effect of Human Leukocyte Antigen Macthing on Guiding Tacrolimus Regimen After Liver Transplantation

    Not yet reported The First Hospital of Jilin University 120 participants Est. completion 2025-04 Stand-alone
    Other conditions: Liver Transplantation, Graft Versus Host Disease, Graft Rejection, Drug-Related Side Effects and Adverse Reactions
    View official trial listing →
  • Completed NCT NCT03162237

    Safety and Efficacy Study of Islets Xenotransplantation

    Not yet reported Wei Wang,MD 20 participants Est. completion 2018-12 1 site Stand-alone
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Status unknown NCT NCT03199664

    Effectiveness of Narrow-band Ultraviolet B Combined With Topical Tacrolimus 0.03% in Treatment of Patients With Vitiligo

    Not yet reported South Valley University 100 participants Est. completion 2018-12-01 1 site
    Other conditions: Vitiligo
    View official trial listing →
  • Completed NCT NCT03222687

    Tacrolimus in Children With Henoch-Schönlein Purpura Nephritis

    Not yet reported Shandong University 25 participants Est. completion 2017-05-31 Stand-alone
    Other conditions: Henoch-Schönlein Purpura Nephritis
    View official trial listing →
  • Terminated NCT NCT03228576

    Prospective Cohort of Kidney Transplanted Patients Receiving an Extended Releasing Tacrolimus-Everolimus Association

    Poitiers University Hospital 16 participants Est. completion 2018-12-18 9 sites
    Other conditions: Kidney Transplant, Immunosuppression
    View official trial listing →
  • Status unknown NCT NCT03234673

    The Effect of Fractional Co2 Laser Either With Tacrolimus, Calcipotriol or NB-UVB in Stable Generalized Vitiligo

    Not yet reported Assiut University 30 participants Est. completion 2019-01 Stand-alone
    Other conditions: Vitiligo Vulgaris
    View official trial listing →
  • Withdrawn NCT NCT03240822

    Human Penile Tissue Allotransplantation for Devastating Penile and Concomitant Genital Trauma

    Not yet reported Wake Forest University Health Sciences Est. completion 2025-12 Stand-alone
    Other conditions: Urologic Injuries, Genital Diseases, Male, Amputation
    View official trial listing →
  • Status unknown NCT NCT03259256

    Islet Allotransplantation for Type 1 Diabetic Patients

    Not yet reported Second Affiliated Hospital of Guangzhou Medical University 5 participants Est. completion 2019-06-30 1 site Stand-alone
    Other conditions: Type 1 Diabetic
    View official trial listing →
  • Completed NCT NCT03263052

    Converting Elderly Kidney Transplant Recipients From Tacrolimus to Envarsus to Limit Neurological AE and Improve QOL

    University of Illinois at Chicago 40 participants Est. completion 2020-01-01 1 site
    Other conditions: Disorder Related to Renal Transplantation
    View official trial listing →
  • Active, not recruiting NCT NCT03266393

    Envarsus XR® in Adolescent Renal Transplant Recipients

    Not yet reported University of California, Los Angeles 28 participants Est. completion 2023-03-31 1 site Stand-alone
    Other conditions: Kidney Transplantation, Renal Transplantation, Grafting, Kidney
    View official trial listing →
  • Withdrawn NCT NCT03315052

    Budesonide for Immunosuppression After Liver Transplantation to Reduce Side Effects

    Not yet reported Montefiore Medical Center Est. completion 2022-01 Stand-alone
    Other conditions: Acute Cellular Graft Rejection, Liver Transplant Rejection
    View official trial listing →
  • Completed NCT NCT03315858

    NFAT-regulated Gene Expression After Tacrolimus

    Medical University of Graz 40 participants Est. completion 2021-11-29 1 site
    Other conditions: NFAT Regulated Gene Expression in Tacrolimus Treated Patients
    View official trial listing →
  • Completed NCT NCT03373227

    Phase II Study Evaluating the Efficacy of Tacrolimus Extended Release Tablets to Twice Daily Tacrolimus Dosing Regimen

    Not yet reported Baylor Research Institute 50 participants Est. completion 2023-12-30 1 site
    Other conditions: Heart Transplant Rejection, Graft Failure, Compliance, Patient
    View official trial listing →
  • Active, not recruiting NCT NCT03386305

    Evaluate the Clinical Benefits of EnvarsusXR in Post Liver Transplant

    Not yet reported, Not yet reported Albert Einstein Healthcare Network 35 participants Est. completion 2021-12-31 1 site
    Other conditions: Post Liver Transplant
    View official trial listing →
  • Completed NCT NCT03386539

    Tacrolimus/Everolimus vs. Tacrolimus/MMF in Pediatric Heart Transplant Recipients Using the MATE Score

    Not yet reported Boston Children's Hospital 211 participants Est. completion 2023-05-17 25 sites Stand-alone
    Chronic kidney disease Other conditions: Pediatric Heart Transplantation, Immunosuppression, Cardiac Allograft Vasculopathy, Heart Transplant Failure and Rejection, Post-transplant Lymphoproliferative Disorder, Heart Transplant Infection
    View official trial listing →
  • Status unknown NCT NCT03425071

    Monitoring Concentration and Pharmacodynamic Effects of Tacrolimus in Peripheral Blood Lymphocytes of Kidney Transplant Recipients

    University of Sao Paulo General Hospital 45 participants Est. completion 2018-12 1 site
    Other conditions: Kidney Transplantation, Rejection
    View official trial listing →
  • Status unknown NCT NCT03438773

    Prospective Pilot Feasibility Study Comparing Envarsus Once-a-day to Tacrolimus Twice-a-day Immunosuppressive Regimen on Drug Bioavailability in Hispanic First Time Kidney Transplant Recipients

    Not yet reported California Institute of Renal Research 50 participants Est. completion 2023-12 1 site
    Other conditions: Kidney Transplant; Complications, Kidney Transplant Failure and Rejection
    View official trial listing →
  • Completed NCT NCT03441958

    ECT-001 (UM171) Expanded Cord Blood Transplant to Treat High-risk Multiple Myeloma

    Not yet reported, Not yet reported Ciusss de L'Est de l'Île de Montréal 19 participants Est. completion 2025-10-17 1 site Stand-alone
    Other conditions: Multiple Myeloma
    View official trial listing →
  • Completed NCT NCT03465410

    OPTImization of the Dose of tacroliMUS by Bayesian Prediction

    Not yet reported NURIA LLOBERAS BLANCH 96 participants Est. completion 2020-09-21 2 sites Stand-alone
    Other conditions: KIDNEY TRANSPLANTATION
    View official trial listing →
  • Active, not recruiting NCT NCT03478215

    Mesenchymal Stromal Cells in Living Donor Kidney Transplantation

    Not yet reported The Methodist Hospital Research Institute 24 participants Est. completion 2026-12 1 site Stand-alone
    Other conditions: Renal Transplantation, Mesenchymal Stem Cells
    View official trial listing →
  • Completed NCT NCT03511560

    Envarsus on the Effect of Total Tacrolimus Dose/Trough Level Ratio on Renal Function (eGFR) in Kidney Transplantation

    Not yet reported Columbia University 50 participants Est. completion 2021-07-17 1 site Stand-alone
    Other conditions: Renal Transplant Rejection, Kidney Transplant Failure and Rejection
    View official trial listing →
  • Status unknown NCT NCT03557203

    Dermatologic Tacrolimus Ointment on Eyelids in the Treatment of Refractory Vernal Keratoconjunctivitis and Atopic Keratoconjunctivitis

    National Taiwan University Hospital 10 participants Est. completion 2019-05-31 1 site
    Other conditions: Vernal Keratoconjunctivitis, Atopic Keratoconjunctivitis, Tacrolimus
    View official trial listing →
  • Completed NCT NCT03558373

    The Adherence of Immunosuppressive Therapy Including Tacrolimus Once-daily in Italian Kidney Transplant Recipients

    Chiesi Farmaceutici S.p.A. 158 participants Est. completion 2020-02-26 12 sites
    Other conditions: Kidney Transplant
    View official trial listing →
  • Completed NCT NCT03582878

    Sirolimus vs Mycophenolate With Tacrolimus in Simultaneous Pancreas and Kidney Transplantation

    Not yet reported Institute for Clinical and Experimental Medicine 238 participants Est. completion 2019-01-01 1 site
    Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Terminated NCT NCT03591380

    CAMPath and BELimumab for Transplant Tolerance in Sensitized Kidney Transplant Recipients

    Not yet reported University of Wisconsin, Madison 3 participants Est. completion 2021-12-03 1 site Stand-alone
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Withdrawn NCT NCT03596970

    Study of the Effect of Everolimus Immunosuppressive Combination Therapies on Renal Function When Used as a Maintenance Treatment for Liver Transplant Patients.

    Not yet reported Novartis Pharmaceuticals Est. completion 2020-12
    Other conditions: Liver Transplantation
    View official trial listing →
  • Status unknown NCT NCT03601208

    Mitra v Fingerprick Tacrolimus Creatinine

    Not yet reported Nottingham University Hospitals NHS Trust 100 participants Est. completion 2019-01 Stand-alone
    Other conditions: Transplant;Failure,Kidney
    View official trial listing →
  • Withdrawn NCT NCT03602898

    Comparing ATG or Post-Transplant Cyclophosphamide to Calcineurin Inhibitor-Methotrexate as GVHD Prophylaxis After Myeloablative Unrelated Donor Peripheral Blood Stem Cell Transplantation

    Not yet reported Fred Hutchinson Cancer Center Est. completion 2023-09-17 1 site Stand-alone
    Other conditions: Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia, Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Hematopoietic and Lymphoid System Neoplasm, Myelodysplastic Syndrome, Myelofibrosis, Myeloproliferative Neoplasm, Recurrent Acute Myeloid Leukemia, Recurrent Hodgkin Lymphoma, Recurrent Non-Hodgkin Lymphoma, Refractory Acute Myeloid Leukemia, Therapy-Related Acute Myeloid Leukemia
    View official trial listing →
  • Status unknown NCT NCT03603548

    Comparison of Safety and Efficacy of Two Variants of Prolonged - Released Tacrolimus (Advagraf vs. Envarsus ) in Patients After Liver Transplantation : Single Center Randomised Control Trial

    Not yet reported Medical University of Warsaw 200 participants Est. completion 2023-07-09 1 site Stand-alone
    Other conditions: Liver Transplant Rejection, Immunosuppression
    View official trial listing →
  • Withdrawn NCT NCT03605654

    Cellular Immunotherapy in Recipients of Human Leukocyte Antigen (HLA)-Mismatched, Living Donor Kidney Transplants

    Not yet reported, Not yet reported Medeor Therapeutics, Inc. Est. completion 2026-10
    Other conditions: Kidney Transplant Rejection
    View official trial listing →
  • Completed NCT NCT03605927

    CD40-L Blockade for Prevention of Acute Graft-Versus-Host Disease

    Not yet reported H. Lee Moffitt Cancer Center and Research Institute 45 participants Est. completion 2023-07-25 3 sites Stand-alone
    Other conditions: Graft-versus-host-disease, GVHD, GVHD, Acute
    View official trial listing →
  • Terminated NCT NCT03654040

    Liver Transplantation With Tregs at UCSF

    Not yet reported, Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 42 participants Est. completion 2023-03-06 1 site Stand-alone
    Other conditions: Liver Transplant
    View official trial listing →
  • Status unknown NCT NCT03672110

    Slow and Low Start of a Tacrolimus Once Daily Immunosuppressive Regimen

    Not yet reported Technische Universität Dresden 400 participants Est. completion 2025-12 1 site Stand-alone
    Other conditions: Renal Failure, Renal Insufficiency, Renal Disease, Renal Insufficiency, Chronic
    View official trial listing →
  • Active, not recruiting NCT NCT03674411

    Trial Evaluating MGTA-456 in Patients With High-Risk Malignancy

    Not yet reported Masonic Cancer Center, University of Minnesota 22 participants Est. completion 2026-12-01 1 site Stand-alone
    Other conditions: Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, Biphenotypic/Undifferentiated Leukemia, Chronic Myelogenous Leukemia, Myelodysplasia, Relapsed Large Cell Lymphoma, Mantle Cell Lymphoma, Hodgkin Lymphoma, Burkitt Lymphoma, Relapsed T-Cell Lymphoma, Lymphoplasmacytic Lymphoma
    View official trial listing →
  • Terminated NCT NCT03689075

    Extended Release Versus Immediate Release Tacrolimus Following Renal Allograft Failure to Reduce Allosensitisation

    Not yet reported Imperial College Healthcare NHS Trust 35 participants Est. completion 2025-02-25 1 site
    Other conditions: Kidney Transplant Failure, Allosensitization, Immunosuppression
    View official trial listing →
  • Completed NCT NCT03699631

    PROACTIVE: Preventing Acute/Chronic GVHD With TocIlizumab Combined With GVHD Prophylaxis Post allogEneic Transplant

    Not yet reported Medical College of Wisconsin 29 participants Est. completion 2023-04-01 1 site Stand-alone
    Other conditions: Hematologic Malignancy
    View official trial listing →
  • Active, not recruiting NCT NCT03726307

    Allogeneic Regulatory Dendritic Cell (DCreg) Renal Study

    Not yet reported Angus W. Thomson PhD DSc 28 participants Est. completion 2028-05 1 site Stand-alone
    Other conditions: Kidney Transplant, Renal Transplant Recipients
    View official trial listing →
  • Active, not recruiting NCT NCT03779854

    Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant

    Not yet reported Fred Hutchinson Cancer Center 45 participants Est. completion 2028-12-31 9 sites Stand-alone
    Other conditions: Acute Biphenotypic Leukemia, Acute Leukemia, Acute Leukemia of Ambiguous Lineage, Acute Lymphoblastic Leukemia, Acute Undifferentiated Leukemia, Allogeneic Hematopoietic Stem Cell Transplantation Recipient, Blastic Plasmacytoid Dendritic Cell Neoplasm, Blasts Under 25 Percent of Bone Marrow Nucleated Cells, Blasts Under 5 Percent of Bone Marrow Nucleated Cells, Mixed Phenotype Acute Leukemia, Myelodysplastic Syndrome With Excess Blasts-1, Myelodysplastic Syndrome/Acute Myeloid Leukemia, Burkitt Leukemia, Chronic Monocytic Leukemia, Lymphoblastic Lymphoma, Mast Cell Leukemia, Myeloproliferative Neoplasm
    View official trial listing →
  • Completed NCT NCT03794492

    Impact of Lymphocyte Anti-metabolite Immunosuppressions on Donor-Specific Anti-HLA Antibody and Kidney Graft Outcome

    Not yet reported Chong Kun Dang Pharmaceutical 169 participants Est. completion 2023-04-27 1 site Stand-alone
    Other conditions: Kidney Transplant
    View official trial listing →
  • Completed NCT NCT03799770

    ONSD and Neurotoxicity in Liver Transplant

    Mansoura University 100 participants Est. completion 2021-03-23 1 site
    Other conditions: Liver Transplant; Complications
    View official trial listing →
  • Completed NCT NCT03800576

    Clinical Outcome of Liver Transplant Patients With Tacrolimus-based Immunosuppression

    National Taiwan University Hospital 113 participants Est. completion 2020-09-22 1 site
    Other conditions: Liver Transplantation
    View official trial listing →
  • Completed NCT NCT03828019

    Adalimumab vs. Conventional Immunosuppression for Uveitis Trial

    Not yet reported JHSPH Center for Clinical Trials 227 participants Est. completion 2024-09-09 26 sites
    Other conditions: Uveitis
    View official trial listing →
  • Status unknown NCT NCT03840512

    An Open Label Study of Multiple Doses of Cannabidiol in the Prevention of Acute Graft-Versus-Host Disease (GVHD)

    Not yet reported Kalytera Therapeutics Israel, Ltd. 36 participants Est. completion 2022-12-15 5 sites Stand-alone
    Other conditions: Prevention aGVHD
    View official trial listing →
  • Active, not recruiting NCT NCT03842696

    Vorinostat for Graft vs Host Disease Prevention in Children, Adolescents and Young Adults Undergoing Allogeneic Blood and Marrow Transplantation

    Not yet reported, Not yet reported University of Michigan Rogel Cancer Center 43 participants Est. completion 2026-04-01 7 sites Stand-alone
    Other conditions: Hematologic Diseases, Acute Leukemia in Remission, Chronic Myelogenous Leukemia - Chronic Phase, Chronic Myelogenous Leukemia, Accelerated Phase, Chronic Myelogenous Leukemia, Blastic Phase, Myelodysplastic Syndromes, Mantle Cell Lymphoma, Follicular Lymphoma, Diffuse Large B Cell Lymphoma, Non Hodgkin Lymphoma, Graft Vs Host Disease, Graft-versus-host-disease
    View official trial listing →
  • Completed NCT NCT03864926

    Envarsus in Delayed Graft Function (E-DGF)

    Not yet reported University of Wisconsin, Madison 100 participants Est. completion 2022-07-22 1 site Stand-alone
    Other conditions: Delayed Graft Function
    View official trial listing →
  • Completed NCT NCT03865888

    Comparing Effect of Topical Tacrolimus 0.03% Versus Cyclosporine 0.05% in Dry Eyes of Secondary Sjogren Syndrome

    Not yet reported Pavly Moawd 60 participants Est. completion 2019-04-30 1 site
    Other conditions: Dry Eye, Sjogren Syndrome
    View official trial listing →
  • Completed NCT NCT03871361

    Abatacept in Patients With Birdshot HLA A29 Uveitis

    Not yet reported Universitaire Ziekenhuizen KU Leuven 15 participants Est. completion 2023-12-01 1 site Stand-alone
    Other conditions: Eye Diseases, Uveitis
    View official trial listing →
  • Status unknown NCT NCT03886233

    Treatment Outcome of Uveitis in Autoimmune Diseases

    Assiut University 1 participants Est. completion 2021-02
    Other conditions: Autoimmune Uveitis
    View official trial listing →
  • Completed NCT NCT03959241

    TAC/MTX vs. TAC/MMF/PTCY for Prevention of Graft-versus-Host Disease and Microbiome and Immune Reconstitution Study (BMT CTN 1703/1801)

    Not yet reported Medical College of Wisconsin 431 participants Est. completion 2022-09-19 39 sites Stand-alone
    Other conditions: Acute Leukemia, Chronic Myelogenous Leukemia (CML), Myelodysplasia, Lymphoma
    View official trial listing →
  • Terminated NCT NCT04002115

    Clofarabine Pre-conditioning Followed by Stem Cell Transplant for Non-remission AML

    Not yet reported Milton S. Hershey Medical Center 2 participants Est. completion 2022-11-07 1 site Stand-alone
    Other conditions: Acute Myeloid Leukemia
    View official trial listing →
  • Completed NCT NCT04009525

    Hematopoietic Stem Cell Transplantation for Patients With Thalassemia Major: A Multicenter, Prospective Clinical Study

    Not yet reported First Affiliated Hospital of Guangxi Medical University 823 participants Est. completion 2023-10-31 1 site Stand-alone
    Other conditions: Thalassemia Major
    View official trial listing →
  • Status unknown NCT NCT04013620

    CNI Transient Replacement by Belatacept From 3 to 12 Months Post Transplantation in Patients With Early Graft Dysfunction

    Not yet reported Nantes University Hospital 48 participants Est. completion 2022-07-09 1 site Stand-alone
    Other conditions: Chronic Kidney Failure
    View official trial listing →
  • Completed NCT NCT04048161

    Study of Tacrolimus vs Mycophenolate Mofetil in Pediatric Patients With Nephrotic Syndrome

    Not yet reported The Children's Hospital of Zhejiang University School of Medicine 270 participants Est. completion 2023-07-12 12 sites Stand-alone
    Other conditions: Nephrotic Syndrome in Children
    View official trial listing →
  • Status unknown NCT NCT04069065

    Efficacy and Safety of Once-Daily Tacrolimus in Liver Transplant Recipients (SOUL)

    Not yet reported Chong Kun Dang Pharmaceutical 146 participants Est. completion 2021-04-08 1 site Stand-alone
    Other conditions: Liver Transplant
    View official trial listing →
  • Completed NCT NCT04102943

    Study to Evaluate the Pharmacokinetics and Tolerability of Tacrolimus in Kidney Transplant Recipients.

    Not yet reported Chong Kun Dang Pharmaceutical 128 participants Est. completion 2020-09-29 1 site Stand-alone
    Other conditions: Kidney Transplant
    View official trial listing →
  • Completed NCT NCT04104438

    Examination of Immunosuppression Adjustment Impact on Kidney Function in Liver Transplant

    Not yet reported Fady M Kaldas, M.D., F.A.C.S. 71 participants Est. completion 2024-09-30 1 site
    Other conditions: Asses Immunosuppression Modulation on Renal Recovery Post LT
    View official trial listing →
  • Completed NCT NCT04118075

    PT-CY With or Without Low-dose ATG for Lymphoid Malignancies Undergoing Allo-HSCT

    Not yet reported Shanghai Jiao Tong University School of Medicine 23 participants Est. completion 2021-05-01 1 site Stand-alone
    Other conditions: GVHD, Acute
    View official trial listing →
  • Withdrawn NCT NCT04127721

    Itacitinib for the Prevention of Graft Versus Host Disease in Patients Undergoing Donor Stem Cell Transplantation

    Not yet reported M.D. Anderson Cancer Center Est. completion 2020-09-22 1 site Stand-alone
    Other conditions: Allogeneic Stem Cell Transplant Recipient, Hematologic and Lymphocytic Disorder, Hematopoietic and Lymphoid Cell Neoplasm
    View official trial listing →
  • Active, not recruiting NCT NCT04262843

    Total Marrow and Lymphoid Irradiation as Conditioning Regimen Before Hematopoietic Cell Transplantation in Patients With Myelodysplastic Syndrome or Acute Leukemia

    Not yet reported City of Hope Medical Center 33 participants Est. completion 2027-05-11 1 site Stand-alone
    Other conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, High Risk Myelodysplastic Syndrome, Myelodysplastic Syndrome
    View official trial listing →
  • Withdrawn NCT NCT04263519

    A Pilot Open Labeled Study of Tacrolimus in Alzheimer's Disease.

    Not yet reported Massachusetts General Hospital Est. completion 2023-01-01
    Other conditions: Alzheimer Disease, Mild Cognitive Impairment
    View official trial listing →
  • Status unknown NCT NCT04299399

    Corneal Biomechanical Changes of Allergic Conjunctivitis

    Zhongshan Ophthalmic Center, Sun Yat-sen University 100 participants Est. completion 2021-06-30 1 site
    Other conditions: Conjunctivitis, Allergic, Keratoconus
    View official trial listing →
  • Completed NCT NCT04339101

    Itacitinib, Tacrolimus, and Sirolimus for the Prevention of GVHD in Patients With Acute Leukemia, Myelodysplastic Syndrome, or Myelofibrosis Undergoing Reduced Intensity Conditioning Donor Stem Cell Transplantation

    Not yet reported City of Hope Medical Center 59 participants Est. completion 2025-10-09 1 site Stand-alone
    Other conditions: Acute Leukemia, Hematologic and Lymphocytic Disorder, Myelodysplastic Syndrome, Primary Myelofibrosis, Secondary Myelofibrosis
    View official trial listing →
  • Completed NCT NCT04380311

    Precision Guided Tacrolimus Dosing in Pediatric Heart Transplant

    Not yet reported University of Utah 17 participants Est. completion 2025-04-30 2 sites Stand-alone
    Other conditions: Heart Transplant Failure and Rejection
    View official trial listing →
  • Active, not recruiting NCT NCT04384692

    Peritransplant Ruxolitinib for Patients With Primary and Secondary Myelofibrosis

    Not yet reported Fred Hutchinson Cancer Center 53 participants Est. completion 2030-04-23 1 site Stand-alone
    Other conditions: Primary Myelofibrosis, Secondary Myelofibrosis
    View official trial listing →
  • Completed NCT NCT04403321

    Efficacy and Safety of Eltrombopag + Tacrolimus in Chinese Refractory or Relapsed Aplastic Anemia Patients

    Not yet reported Peking Union Medical College Hospital 114 participants Est. completion 2022-07-31 1 site Stand-alone
    Other conditions: Aplastic Anemia, Drug Effect
    View official trial listing →
  • Completed NCT NCT04420195

    Envarsus XR in Lung Transplant

    Not yet reported NYU Langone Health 41 participants Est. completion 2022-11-30 1 site Stand-alone
    Other conditions: Lung Transplant
    View official trial listing →
  • Completed NCT NCT04431219

    First in Human Study: LIS1, an Induction Treatment in Kidney Transplanted Patients

    Not yet reported, Not yet reported Xenothera SAS 10 participants Est. completion 2022-03-28 1 site Stand-alone
    Other conditions: Kidney Transplant
    View official trial listing →
  • Status unknown NCT NCT04444843

    Risk Factors of Chinese Kidney Transplant Recipients DSA Based on MPA Immunosuppressive Regimen

    Not yet reported First Affiliated Hospital Xi'an Jiaotong University 300 participants Est. completion 2023-12-31 1 site
    Other conditions: Kidney Transplant Recipients
    View official trial listing →
  • Completed NCT NCT04532710

    Therapeutic Effect of Tacrosolv in Patients With Allergic Rhinoconjunctivitis

    Not yet reported Marinomed Biotech AG 64 participants Est. completion 2021-05-27 1 site
    Other conditions: Allergic Conjunctivitis, Allergic Rhinitis
    View official trial listing →
  • Completed NCT NCT04539470

    Study to Evaluate the Safety and Pharmacokinetics of Efmarodocokin Alfa in Combination With Standard of Care in Participants Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

    Not yet reported Genentech, Inc. 18 participants Est. completion 2023-02-24 8 sites Stand-alone
    Other conditions: Acute Graft-versus-host Disease
    View official trial listing →
  • Active, not recruiting NCT NCT04629248

    A Study Evaluating the Efficacy and Safety of Obinutuzumab in Participants With Primary Membranous Nephropathy

    Not yet reported Hoffmann-La Roche 142 participants Est. completion 2027-12-21 50 sites
    Other conditions: Primary Membranous Nephropathy
    View official trial listing →
  • Completed NCT NCT04646356

    Tacrolimus Trial for Hereditary Hemorrhagic Telangiectasia (HHT)

    Not yet reported Unity Health Toronto 10 participants Est. completion 2024-10-21 1 site Stand-alone
    Other conditions: Hereditary Hemorrhagic Telangiectasia, Epistaxis Nosebleed
    View official trial listing →
  • Withdrawn NCT NCT04711291

    Efficacy of Envarsus XR and Digital Health Technology in Reducing Tacrolimus Fluctuation and Frequency of Dose Changes

    Not yet reported Beth Israel Deaconess Medical Center Est. completion 2023-07-01 Stand-alone
    Other conditions: Medication Adherence, Renal Transplant
    View official trial listing →
  • Completed NCT NCT04718311

    Study on Treatment for Patients With Symptomatic Oral Lichen Planus

    Not yet reported University of Catania 60 participants Est. completion 2020-03-20 1 site
    Other conditions: Lichen Planus, Oral
    View official trial listing →
  • Status unknown NCT NCT04747080

    The Combination of Tacrolimus and High-dose Dexamethasone as First-line Treatment in Adult Immune Thrombocytopenia

    Not yet reported Peking University People's Hospital 120 participants Est. completion 2023-07-01 1 site Stand-alone
    Other conditions: ITP, Immune Thrombocytopenia
    View official trial listing →
  • Completed NCT NCT04761731

    To Evaluate the Efficacy and Safety of ADVAGRAF® After Treatment With a Tacrolimus in New Liver Transplant Recipients

    Not yet reported Linical Korea 31 participants Est. completion 2017-12-14 Stand-alone
    Other conditions: Liver Transplantation
    View official trial listing →
  • Status unknown NCT NCT04765826

    Comparison Between Systemic Steroids, Topical Steroids, or Calcineurin Inhibitors With Mini Punch Grafting in Treatment of Stable Non-segmental Vitiligo

    Not yet reported Alexandria University 60 participants Est. completion 2022-08 1 site Stand-alone
    Other conditions: Vitiligo
    View official trial listing →
  • Completed NCT NCT04788641

    Study to Assess the Effect of Sodium Zirconium Cyclosilicate on the Pharmacokinetics of Tacrolimus and Cyclosporin in Healthy Subjects

    Not yet reported AstraZeneca 62 participants Est. completion 2021-09-16 1 site Stand-alone
    Other conditions: Hyperkalaemia
    View official trial listing →
  • Completed NCT NCT04810143

    Tacrolimus Microsampling

    Not yet reported Children's Hospital Medical Center, Cincinnati 16 participants Est. completion 2022-07-28 1 site Stand-alone
    Obstructive sleep apnea
    View official trial listing →
  • Completed NCT NCT04825262

    Efficacy of Achieving Early Target Trough Levels of Tacrolimus Using CYP3A5 Guided Dosing Versus Weight-based Dosing in a Multi-ethnic Population of Kidney Transplant Recipients in Singapore

    Not yet reported Singapore General Hospital 74 participants Est. completion 2024-04-09 1 site Stand-alone
    Other conditions: Kidney Transplant Rejection, Kidney Transplant; Complications
    View official trial listing →
  • Active, not recruiting NCT NCT04859946

    Itacitinib for the Prevention of Graft Versus Host Disease

    Not yet reported M.D. Anderson Cancer Center 31 participants Est. completion 2027-04-01 1 site Stand-alone
    Other conditions: Hematologic and Lymphocytic Disorder
    View official trial listing →
  • Active, not recruiting NCT NCT04953715

    Microbiome and Immunosuppression: The Mission Study

    The University of Texas Medical Branch, Galveston 140 participants Est. completion 2033-01-01 2 sites
    Other conditions: Kidney Transplant Rejection, Kidney Transplant
    View official trial listing →
  • Withdrawn NCT NCT04973982

    ENvarsus for Impaired Glucose Tolerance Post REnal transplAnT

    Not yet reported Barts & The London NHS Trust Est. completion 2022-10-01 1 site
    Other conditions: Renal Transplant Failure
    View official trial listing →
  • Completed NCT NCT05005221

    Home-based Therapeutic Drug Monitoring in Kidney Transplantation

    Not yet reported University of Michigan 41 participants Est. completion 2024-05-08 1 site Stand-alone
    Other conditions: Kidney Transplant
    View official trial listing →
  • Status unknown NCT NCT05011916

    The Safety and Efficacy of KDR2-2 Suspension Eye Drops in the Treatment of Corneal Neovascularization

    Not yet reported, Not yet reported Zhongshan Ophthalmic Center, Sun Yat-sen University 60 participants Est. completion 2022-08-09 2 sites
    Other conditions: Corneal Neovascularization
    View official trial listing →
  • Completed NCT NCT05077254

    COVID Protection After Transplant-Immunosuppression Reduction

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 48 participants Est. completion 2025-02-21 15 sites
    Other conditions: Kidney Transplant Recipients, Liver Transplant Recipients
    View official trial listing →
  • Completed NCT NCT05139667

    Evaluation of Mucoadhesive Tacrolimus Patch on Caspase-3 Inducing Apoptosis in Oral Lichen Planus

    Not yet reported Ain Shams University 30 participants Est. completion 2021-10-20 1 site Stand-alone
    Other conditions: Oral Lichen Planus
    View official trial listing →
  • Active, not recruiting NCT NCT05148715

    Calcineurin Inhibitor in NEuRoloGically Deceased Donors to Decrease Kidney delaYed Graft Function (CINERGY)

    Not yet reported Université de Sherbrooke 414 participants Est. completion 2026-01 9 sites Stand-alone
    Other conditions: Organ Transplant Failure or Rejection, Brain Death, Ischemic Reperfusion Injury
    View official trial listing →
  • Completed NCT NCT05202145

    Drug-Drug Interaction (DDI) Study of ALXN2050 in Healthy Adult Participants

    Not yet reported Alexion Pharmaceuticals, Inc. 61 participants Est. completion 2022-03-21 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Status unknown NCT NCT05221411

    Tacrolimus Versus Mycophenolate for Autoimmune Hepatitis Patients With Incomplete Response on First Line Therapy

    Not yet reported Leiden University Medical Center 86 participants Est. completion 2024-01 6 sites Stand-alone
    Other conditions: Autoimmune Hepatitis
    View official trial listing →
  • Active, not recruiting NCT NCT05256537

    Fludarabine and Total Body Irradiation 800 Centigray (cGy) or 1125 cGy For Allogeneic Stem Cell Transplant Using Graft Versus Host Disease Prophylaxis With Post-Transplant Cyclophosphamide and Tacrolimus, Without Mycophenolate Mofetil

    Not yet reported Ronald Paquette 60 participants Est. completion 2027-01-07 1 site
    Other conditions: Hematologic Neoplasms
    View official trial listing →
  • Completed NCT NCT05294666

    Evaluation of 0.05% CsA and 0.1% FK506 Eye Drops in Ocular GVHD Treatment

    Not yet reported Peking University Third Hospital 89 participants Est. completion 2021-07-01 1 site Stand-alone
    Other conditions: Graft Versus Host Disease in Eye
    View official trial listing →
  • Status unknown NCT NCT05294822

    Autologous Regenerative Islet Transplantation for Insulin-dependent Diabetes

    Not yet reported Shanghai Changzheng Hospital 20 participants Est. completion 2023-12 1 site Stand-alone
    Other conditions: Diabetes
    View official trial listing →
  • Active, not recruiting NCT NCT05316701

    Precision-T: A Randomized Study of Orca-T in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies

    Not yet reported Orca Biosystems, Inc. 187 participants Est. completion 2026-07 19 sites Stand-alone
    Other conditions: Acute Myeloid Leukemia, Acute Lymphoid Leukemia, Mixed Phenotype Acute Leukemia, Undifferentiated Leukemia, Myelodysplastic Syndrome, Acute Leukemia, Therapy-Related Myelodysplastic Syndrome
    View official trial listing →
  • Completed NCT NCT05490511

    Drug-gene-nutraceutical Interactions of Cannabidiol and Tacrolimus

    Not yet reported Indiana University 57 participants Est. completion 2025-08-31 1 site
    Other conditions: CBD, Transplant Complication, Kidney Disease, Chronic
    View official trial listing →
  • Status unknown NCT NCT05546047

    A Study of Acthar Gel Alone or With Tacrolimus to Reduce Proteinuria in Fibrillary Glomerulopathy Patients

    Not yet reported NephroNet, Inc. 34 participants Est. completion 2024-10-27 5 sites
    Other conditions: Fibrillary Glomerulonephritis
    View official trial listing →
  • Completed NCT NCT05577637

    Comparitive Study Between Uvb Alone and Uvb With Topical Tacrolimus 0.03% for the Treatment of Vitiligo

    Not yet reported Combined Military Hospital Abbottabad 60 participants Est. completion 2021-11-30 1 site
    Other conditions: Vitiligo
    View official trial listing →
  • Completed NCT NCT05607901

    A Comparative Clinical Trial Evaluating the Effect and Safety of Tacrolimus Versus Hydrocortisone

    Not yet reported Tanta University 100 participants Est. completion 2023-11-20 1 site
    Other conditions: Dermatologic Disease
    View official trial listing →
  • Active, not recruiting NCT NCT05621759

    Cyclophosphamide, Abatacept, and Tacrolimus for the Prevention of GvHD

    Not yet reported NYU Langone Health 27 participants Est. completion 2027-01-30 1 site Stand-alone
    Other conditions: Graft Vs Host Disease
    View official trial listing →
  • Active, not recruiting NCT NCT05622318

    De-escalated Cyclophosphamide (PTCy) and Ruxolitinib for Graft-versus-Host Disease (GVHD) Prophylaxis

    Not yet reported Medical College of Wisconsin 56 participants Est. completion 2026-09 1 site Stand-alone
    Other conditions: Graft-versus-host Disease
    View official trial listing →
  • Enrolling by invitation NCT NCT05655273

    Conversion of Maintenance Prograf to Envarsus in Liver Transplant Recipients

    Not yet reported University Health Network, Toronto 40 participants Est. completion 2026-02-28 1 site
    Other conditions: Liver Transplant Rejection, Immune System Suppression
    View official trial listing →
  • Status unknown NCT NCT05667896

    Prognostic Model of GC/TAC in the Treatment of MN

    Qianfoshan Hospital 50 participants Est. completion 2023-12
    Other conditions: Idiopathic Membranous Nephropathy
    View official trial listing →
  • Completed NCT NCT05669001

    A Study of TCD601 in de Novo Renal Transplant Recipients

    Not yet reported ITB-Med LLC 76 participants Est. completion 2026-04-10 18 sites
    Other conditions: Renal Transplantation
    View official trial listing →
  • Status unknown NCT NCT05678335

    Tacrolimus for Thrombocytopenia in SS

    Not yet reported, Not yet reported Peking Union Medical College Hospital 54 participants Est. completion 2024-03 Stand-alone
    Other conditions: Sjogren Syndrome With Other Organ Involvement
    View official trial listing →
  • Status unknown NCT NCT05797038

    Study on the Application of Hyperspectral Imaging Technique in the Treatment of IMN by TAC

    Qianfoshan Hospital 40 participants Est. completion 2023-12-30
    Other conditions: Idiopathic Membranous Nephropathy, Tacrolimus, Hyperspectral Imaging
    View official trial listing →
  • Status unknown NCT NCT05863936

    Trial of Belimumab Combined With Multi-target Induction Therapy in Lupus Nephritis

    Not yet reported Nanjing University School of Medicine 15 participants Est. completion 2024-12-31 1 site
    Other conditions: Lupus Nephritis, Remission, Safety Issues
    View official trial listing →
  • Enrolling by invitation NCT NCT05973734

    Islet Transplantation With Recipient T-Reg Cells or Deceased Donor Vertebral Bone Marrow Therapy

    Not yet reported Stanford University 24 participants Est. completion 2030-12 1 site Stand-alone
    Other conditions: Islet Transplantation
    View official trial listing →
  • Completed NCT NCT05975450

    Subcutaneous Abatacept in Renal Transplant Recipients

    Not yet reported Idelberto Badell 16 participants Est. completion 2025-02-14 2 sites Stand-alone
    Other conditions: Kidney Transplant Recipient
    View official trial listing →
  • Status unknown NCT NCT06057545

    Pharmacokinetics, Effectiveness and Tolerability of Prolonged-release Tacrolimus After Paediatric Kidney Transplantation

    Not yet reported University Hospital, Essen 30 participants Est. completion 2025-03 4 sites Stand-alone
    Other conditions: Pediatric Kidney Disease
    View official trial listing →
  • Completed NCT NCT06091995

    Use of Belatacept to Delay Tacrolimus Initiation in Kidney Transplant Patients With Delayed Graft Function

    Methodist Health System 67 participants Est. completion 2025-07-07 1 site
    Other conditions: Use of Belatacept in Kidney Transplant Patients
    View official trial listing →
  • Active, not recruiting NCT NCT06120140

    Enhanced Dermatological Care to Reduce Rash and Paronychia in Epidermal Growth Factor Receptor (EGRF)-Mutated Non-Small Cell Lung Cancer (NSCLC) Treated First-line With Amivantamab Plus Lazertinib

    Not yet reported Janssen Research & Development, LLC 305 participants Est. completion 2030-06-30 93 sites Stand-alone
    Other conditions: Carcinoma, Non-Small-Cell Lung
    View official trial listing →
  • Not yet recruiting NCT NCT06147375

    Efficacy and Safety of Immunosuppressive Withdrawal After Pediatric Liver Transplantation

    Not yet reported Wei Gao 47 participants Est. completion 2028-12 1 site Stand-alone
    Other conditions: Immune Tolerance, Immunosuppression, Liver Transplant; Complications
    View official trial listing →
  • Status unknown NCT NCT06147648

    Early Conversion of Prolonged-release Tacrolimus in Liver Transplantation.

    Not yet reported Beijing Tsinghua Chang Gung Hospital 352 participants Est. completion 2026-07-30 Stand-alone
    Other conditions: Liver Transplantation
    View official trial listing →
  • Not yet recruiting NCT NCT06203470

    Botox Versus Tacrolimus in Psoriasis Vulgaris

    Not yet reported Assiut University 60 participants Est. completion 2026-10 Stand-alone
    Other conditions: Psoriasis Vulgaris
    View official trial listing →
  • Status unknown NCT NCT06225206

    Analysis of Donor-derived Cell Free DNA in Liver Transplant Patients

    Methodist Health System 300 participants Est. completion 2024-12-31 1 site
    Other conditions: Liver Transplant Failure
    View official trial listing →
  • Enrolling by invitation NCT NCT06306274

    Topical Tacrolimus for Breast Cancer-related Lymphedema

    Not yet reported, Not yet reported Odense University Hospital 80 participants Est. completion 2026-03-31 3 sites Stand-alone
    Other conditions: Lymphedema
    View official trial listing →
  • Status unknown NCT NCT06319391

    Analysis of the Effect of Donor CYP3A5 Gene Polymorphism on Early Tacrolimus Concentration and Postoperative Acute Renal Injury After Liver Transplantation

    Ziqiang Li 60 participants Est. completion 2025-10-01 1 site
    Other conditions: Complete and Accurate Statistical Data of 60 Patients, CYP3A5*3 Genotypes of 60 Donors and Recipients Were Analyzed Accurately, Postoperative Tacrolimus Concentrations Were Accurately Recorded in 60 Patients, According to the Diagnosis and Grading Criteria of Acute Kidney Injury, the Cases and Grading of Postoperative Acute Kidney Injury in 60 Patients Were Counted, Scientific and Rigorous Statistical Analysis of Data
    View official trial listing →
  • Status unknown NCT NCT06338306

    Tacrolimus and Personalized Therapy to Prevent Acute Rejection Episodes

    Fondazione IRCCS Policlinico San Matteo di Pavia 25 participants Est. completion 2025-06-30 1 site
    Other conditions: Heart Transplant Failure
    View official trial listing →
  • Completed NCT NCT06342505

    Tacrolimus in CD3+ T Lymphocytes

    Erasmus Medical Center 28 participants Est. completion 2022-11-10 1 site
    Other conditions: Immunosuppression
    View official trial listing →
  • Completed NCT NCT06362005

    The Efficacy of Selenium as an Alternative or Complementary Topical Treatment of Oral Lichen Planus

    Not yet reported Al-Azhar University 50 participants Est. completion 2025-10-01 1 site Stand-alone
    Other conditions: Lichen Planus, Oral
    View official trial listing →
  • Suspended NCT NCT06680661

    ABBA CORD: dCBT w/ Abatacept for aGVHD Prophylaxis

    Not yet reported Leland Metheny 20 participants Est. completion 2028-10-31 1 site Stand-alone
    Other conditions: Acute Myelogenous Leukemia, Acute Lymphatic Leukemia, Chronic Myelogenous Leukemia, Myelodysplastic Syndromes, Myelodysplastic Syndrome Other, Chronic Myelomonocytic Leukemia, Lymphoma, Hodgkin Lymphoma
    View official trial listing →
  • Not yet recruiting NCT NCT06867042

    Tacrolimus Lipid Suspension for Enema in Adult Subjects with Mild to Moderately Active Left-sided/Distal Ulcerative Colitis Who Had an Inadequate Response to the Treatment

    Not yet reported Jina Pharmaceuticals Inc. 150 participants Est. completion 2026-04 Stand-alone
    Other conditions: Ulcerative Colitis (UC), Ulcerative Colitis, Active Moderate
    View official trial listing →
  • Enrolling by invitation NCT NCT06880042

    COMPARISON OF EFFICACY AND SAFETY OF NARROWBAND UVB WITH 0.1% TACROLIMUS VS NARROWBAND UVB WITH 0.005% CALCIPOTRIOL IN TREATMENT OF VITILIGO

    Not yet reported Dr ayesha wahid 60 participants Est. completion 2025-08-30 1 site
    Other conditions: Vitiligo - Macular Depigmentation, Tacrolimus
    View official trial listing →
  • Not yet recruiting NCT NCT07003438

    Study on the Efficacy and Safety of Fecal Microbiota Transplantation in the Treatment of Steroid - Dependent /Steroid-resistant Nephrotic Syndrome in Children

    Not yet reported Zhang Ting 120 participants Est. completion 2028-04-01
    Other conditions: Steroid-Resistant Nephrotic Syndrome, Steroid-Dependent Nephrotic Syndrome
    View official trial listing →
  • Completed NCT NCT07049172

    Rituximab and Targeted Nursing for Pediatric Nephrotic Syndrome

    Not yet reported Wuhan Children's Hospital 91 participants Est. completion 2023-12-31 1 site
    Other conditions: Nephrotic Syndrome in Children
    View official trial listing →
  • Not yet recruiting NCT NCT07083830

    ECP-DL Cell Infusion for Induction in Living Donor Kidney (LDK) Transplants

    Not yet reported Northwestern University 24 participants Est. completion 2029-08-25 Stand-alone
    Other conditions: Kidney Transplant Failure and Rejection, Kidney Transplant; Complications
    View official trial listing →
  • Not yet recruiting NCT NCT07203664

    Use of Tacrolimus and MTOR Inhibitors With Anticipatory Therapy vs. Tacrolimus and Mycophenolic Acid With Universal Prophylaxis in Renal Recipients at High Risk of Posttransplant Cytomegalovirus.

    Not yet reported Hospital Universitario La Paz 30 participants Est. completion 2026-12-31 1 site Stand-alone
    Other conditions: Evaluate the Effectiveness of CMV Prevention Strategies in Kidney Transplant Recipients
    View official trial listing →
  • Withdrawn NCT NCT07349771

    Axatilimab Plus Standard of Care Therapy for the Prevention of Graft Versus Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Hematologic Cancer, ABRAXAS Trial

    Not yet reported Mayo Clinic Est. completion 2033-06-01 3 sites Stand-alone
    Other conditions: Hematopoietic and Lymphatic System Neoplasm
    View official trial listing →
  • Not yet recruiting NCT NCT07367932

    Comparative Study of Crisaborole vs. Tacrolimus in Atopic Dermatitis

    Not yet reported Cairo University 30 participants Est. completion 2026-07
    Other conditions: Dermatitis, Atopic, Eczema
    View official trial listing →
  • Completed NCT NCT07368673

    Comparative Effectiveness of Ruxolitinib Monotherapy Versus Its Combination With Tacrolimus and Corticosteroids in the Management of Vitiligo: A Randomized Controlled Trial

    Not yet reported Dow University of Health Sciences 120 participants Est. completion 2026-01-05 1 site
    Other conditions: Vitiligo
    View official trial listing →
  • Not yet recruiting NCT NCT07524530

    Stem Cell Transplantation for Participants With Germline RUNX1 Associated Blood Cancers

    Not yet reported National Cancer Institute (NCI) 102 participants Est. completion 2036-06-01 1 site Stand-alone
    Other conditions: Core Binding Factor Alpha Subunits, Hematologic Neoplasms, Leukemia, Lymphoma
    View official trial listing →
  • Not yet recruiting NCT NCT07549230

    Model-Informed Precision Dosing of Tacrolimus in Pediatric Kidney Transplantation

    Helwan University 130 participants Est. completion 2027-06-01
    Other conditions: Pediatric Kidney Transplantation
    View official trial listing →
  • Not yet recruiting NCT NCT07572695

    Salvage Haploidentical HSCT With DLI and Targeted Therapy for R/R AML

    Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 40 participants Est. completion 2028-12
    Other conditions: Acute Myeloid Leukemia, Relapsed/Refractory Acute Myeloid Leukemia, AML, Relapsed/Refractory
    View official trial listing →
  • Not yet recruiting NCT NCT07709845

    CC-101 (f/k/a NR1) Neural Stem Cell Transplantation for Adults With Chronic Ischemic Stroke

    Not yet reported Clarion Cells, Inc. 36 participants Est. completion 2029-01 Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Not yet recruiting NCT NCT07713186

    Azithromycin in Atopic Dermatitis

    Not yet reported Cairo University 40 participants Est. completion 2027-01 1 site Stand-alone
    Other conditions: Atopic Dermatitis
    View official trial listing →
  • Not yet recruiting NCT NCT07737249

    Efficacy and Safety of Golidocitinib for Rapidly Progressive Interstitial Lung Disease

    Not yet reported Peking Union Medical College Hospital 60 participants Est. completion 2027-08-31 1 site
    Other conditions: Interstitial Lung Diseases
    View official trial listing →
  • Not yet recruiting NCT NCT07806136

    Biomarker-Guided Mycophenolate Mofetil Elimination in Low-Risk Older Adult Kidney Transplant Recipients

    Not yet reported Virginia Commonwealth University 20 participants Est. completion 2029-08-01 Stand-alone
    Other conditions: Kidney Transplant Recipient
    View official trial listing →
  • Completed NCT NCT07819071

    EFFICACY AND TOLERANCE OF AN EYELID BALM IN COMBINATION WITH TACROLIMUS 0.1% IN PATIENTS WITH EYELID ATOPIC DERMATITIS

    Not yet reported Pierre Fabre Dermo Cosmetique 33 participants Est. completion 2026-01-10 1 site Stand-alone
    Other conditions: Atopic Dermatitis (AD)
    View official trial listing →
Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources

Also known as: Tacrolimus, Prograf, Prograf (SOC)

Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.